JPS6357426B2 - - Google Patents
Info
- Publication number
- JPS6357426B2 JPS6357426B2 JP58153235A JP15323583A JPS6357426B2 JP S6357426 B2 JPS6357426 B2 JP S6357426B2 JP 58153235 A JP58153235 A JP 58153235A JP 15323583 A JP15323583 A JP 15323583A JP S6357426 B2 JPS6357426 B2 JP S6357426B2
- Authority
- JP
- Japan
- Prior art keywords
- halogenated
- vitamin
- group
- formula
- hydroxyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003704 vitamin D3 derivatives Chemical class 0.000 claims description 39
- -1 hydroxymethylene group Chemical group 0.000 claims description 34
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 27
- 125000005843 halogen group Chemical group 0.000 claims description 19
- 239000011575 calcium Substances 0.000 claims description 18
- 229910052791 calcium Inorganic materials 0.000 claims description 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 125000006239 protecting group Chemical group 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 238000006722 reduction reaction Methods 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 238000006317 isomerization reaction Methods 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 150000001993 dienes Chemical class 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 22
- 150000001875 compounds Chemical class 0.000 description 20
- 230000000694 effects Effects 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000007901 soft capsule Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000010511 deprotection reaction Methods 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 5
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 208000025113 myeloid leukemia Diseases 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000003714 granulocyte Anatomy 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010061728 Bone lesion Diseases 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 208000005368 osteomalacia Diseases 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- YUGCAAVRZWBXEQ-WHTXLNIXSA-N previtamin D3 Chemical class C=1([C@@H]2CC[C@@H]([C@]2(CCC=1)C)[C@H](C)CCCC(C)C)\C=C/C1=C(C)CC[C@H](O)C1 YUGCAAVRZWBXEQ-WHTXLNIXSA-N 0.000 description 3
- 210000004765 promyelocyte Anatomy 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- IUWNUFNRBABFDB-LDHZKLTISA-N (8s,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1=CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 IUWNUFNRBABFDB-LDHZKLTISA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000005456 alcohol based solvent Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical class B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 230000003913 calcium metabolism Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- BJYLYJCXYAMOFT-RRXOBRNQSA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCC(O)C(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BJYLYJCXYAMOFT-RRXOBRNQSA-N 0.000 description 1
- PQKFUDVFSOEHDQ-KBBGFLFPSA-N (1s,3r,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5,5-difluoro-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC(F)(F)C(C)(C)O)C)=C\C=C1\C[C@H](O)C[C@@H](O)C1=C PQKFUDVFSOEHDQ-KBBGFLFPSA-N 0.000 description 1
- MWMRKMYVEZHELG-FFTFKNOJSA-N (9s,10r,13r,14r,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthrene Chemical class C1CCC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 MWMRKMYVEZHELG-FFTFKNOJSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 125000002672 4-bromobenzoyl group Chemical group BrC1=CC=C(C(=O)*)C=C1 0.000 description 1
- ISULLEUFOQSBGY-UHFFFAOYSA-N 4-phenyl-1,2,4-triazole-3,5-dione Chemical compound O=C1N=NC(=O)N1C1=CC=CC=C1 ISULLEUFOQSBGY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- QNVAUOOHLRHGAV-UHFFFAOYSA-N C(C)(C)(C)O[AlH2].[Li] Chemical compound C(C)(C)(C)O[AlH2].[Li] QNVAUOOHLRHGAV-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000017733 acquired polycythemia vera Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- JPUHCPXFQIXLMW-UHFFFAOYSA-N aluminium triethoxide Chemical compound CCO[Al](OCC)OCC JPUHCPXFQIXLMW-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical group OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011612 calcitriol Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- USTQSEJKTIDFAG-UHFFFAOYSA-N carboxysulfamoyl-diethyl-propylazanium;hydroxide Chemical compound [OH-].CCC[N+](CC)(CC)S(=O)(=O)NC(O)=O USTQSEJKTIDFAG-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- SYZWSSNHPZXGML-UHFFFAOYSA-N dichloromethane;oxolane Chemical compound ClCCl.C1CCOC1 SYZWSSNHPZXGML-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000000434 field desorption mass spectrometry Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 208000037244 polycythemia vera Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N tert-butyl alcohol Substances CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
ç£æ¥äžã®å©çšåé
æ¬çºæã¯æ°èŠãªæŽ»æ§åãã¿ãã³D3ååç©ã§ã
ã26âããã²ã³åãã¿ãã³D3èªå°äœãã®è£œé æ³
åã³ãããæå¹æåãšããè¬å€ã«é¢ãããæŽã«è©³
现ã«ã¯ãæ¬çºæã¯åªããè¬çäœçšãããªãã¡è žç®¡
ããã®ã«ã«ã·ãŠã åžåèœãä¿é²ããŠè¡äžã®ã«ã«ã·
ãŠã æ¿åºŠãé«ããäœçšåã³éªšå¡©æº¶è§£äœçšãæããŸ
ããããã®è¬çäœçšã®æç¶æéãé·ããããæ ã«
ã«ã«ã·ãŠã 代è¬ç°åžžã«ããèµ·ããçš®ã ã®çŸæ£ãäŸ
ãã°éªšç²é¬çã骚è»åçãªã©ã®éªšç å€çã®æ²»çã
ããã¯äºé²è¬ãšããŠæçšã§ããããããã¯ãŸãäŸ
ãã°ãã骚é«æ§çœè¡ç 现èãæ£åžžçŽ°èã«ååèªå°
ããäœçšãæããè±è «çå€ãšããŠãæçšãª26âã
ãã²ã³åãã¿ãã³D3èªå°äœãã®è£œé æ³åã³ãã
ãæå¹æåãšããè¬å€ã«é¢ããã åŸæ¥æè¡ æŽ»æ§åãã¿ãã³D3ãšããŠã1αïŒ25âãžããã
ãã·ãã¿ãã³D3ã1αïŒ24âãžããããã·ãã¿ã
ã³D3ïŒ1αâããããã·â24âãªããœãã¿ãã³D3ïŒ
24ïŒ24âãžãã«ãªãâ1αïŒ25âãžããããã·ã
ã¿ãã³D3ãªã©ãç¥ãããŠããããããã®ååç©
ã¯ãçäœå ã®ã«ã«ã·ãŠã ã¬ãã«ã調ç¯ãã骚ç²é¬
çã骚è»åçãªã©ã®ãããã骚æžå°çã«æçšã§ã
ãããšãç¥ãããŠãããU.S.Patent No.
4022891ïŒVitamin ïŒBasic Research and
itsclinical ApplicationïŒ1099ã1106ïŒ1979ïŒãã
ãŸ
ããããã®ååç©ã¯ããã骚é«æ§çœè¡ç 现èã®ã
ã¯ããã¢ãŒãžãé¡ç²çãžã®ååèªå°èœãæãè±è «
çå€ãšããŠãæçšã§ããããšãç¥ãããŠãã
ïŒProc.Natl.Acad.Sci.USAïŒVol.78ïŒNo.ïŒïŒ
pp.4990ã4994ïŒ1981ïŒïŒç¹éæ58â149224å·å ¬å ±ã
ç¹éæ57â149224å·å ¬å ±ïŒã ããããªããã24äœã«ãªããœåºãããã¯æ°Žé žåº
ãæãããã€26äœã«ããã²ã³ååãæãã26âã
ãã²ã³åãã¿ãã³D3èªå°äœã¯æç®æªèŒã®æ°èŠå
åç©ã§ããããã®è£œé æ³ãè¬ç掻æ§çã«ã€ããŠã¯
åŸæ¥å šãç¥ãããŠããªãã çºæã®ç®ç æ¬çºæã®ç®çã¯ãæ°èŠååç©ã§ãã€ãŠãåªãã
è¬çäœçšãæãã26âããã²ã³åãã¿ãã³D3èª
å°äœãã®è£œé æ³åã³ãããæå¹æåãšããè¬å€ã
æäŸããããšã«ããã çºæã®æ§æåã³å¹æ æ¬çºæã§æäŸããã26âããã²ã³åãã¿ãã³
D3èªå°äœã¯äžèšåŒãã ãåŒäžãã¯ããã²ã³ååãã¯ããããã·ã¡
ãã¬ã³åºåã¯ã«ã«ããã«åºãã¯æ°ŽçŽ åååã¯æ°Ž
é žåºãè¡šãããã ã§è¡šããããã äžèšåŒããã®26âããã²ã³åãã¿ãã³D3èª
å°äœã¯ã24äœã«ãªããœåºåã¯æ°Žé žåºãæãããã€
26äœã«ããã²ã³ååãæãããã®ã§ãããåŸæ¥å š
ãç¥ãããŠããªãæ§é ãæã€ãŠããã äžèšåŒããã«ãããŠïŒžã¯ããã²ã³ååãè¡šã
ããããã§ããã²ã³ååãšããŠã¯ãããçŽ ãå¡©
çŽ ãèçŽ ããšãŠçŽ ååãæããããšãã§ããã
ã¯ããããã·ã¡ãã¬ã³åºåã¯ã«ã«ããã«åºãè¡šã
ããã¯æ°ŽçŽ åååã¯æ°Žé žåºãè¡šããã ã®å®çŸ©ããäžèšåŒããã®ååç©ã¯æ¬¡ã®åå
ç©ã«åããããã ãããããã·ã¡ãã¬ã³åºã§ãããšããæ¬çºæ
ã®26âããã²ã³åãã¿ãã³D3èªå°äœã¯äžèšåŒ
ãâïœã ãåŒäžãïŒïŒ²ã¯äžèšå®çŸ©ã«åããã ã§è¡šããããååç©ã§ããããã«ã«ããã«åºã§
ãããšãæ¬çºæã®26âããã²ã³åãã¿ãã³D3èª
å°äœã¯äžèšåŒãâïœã ãåŒäžãïŒïŒ²ã¯äžèšå®çŸ©ã«åãã ã§è¡šããããååç©ã§ããã æ¬çºæã®26âããã²ã³åãã¿ãã³D3èªå°äœã®
å ·äœäŸãšããŠã¯æ¬¡ã®ãã®ãæããããã 26âãã«ãªãâ24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âã¯ãã«â24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âããã â24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âãšãŠãâ24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âãã«ãªãâ24ïŒïŒ³ïŒâããããã·ãã¿ãã³
D3ïŒ 26âã¯ãã«â24ïŒïŒ³ïŒâããããã·ãã¿ãã³
D3ïŒ 26âããã â24ïŒïŒ³ïŒâããããã·ãã¿ãã³
D3ïŒ 26âãã«ãªãâ24âãªããœãã¿ãã³D3ïŒ 26âã¯ãã«â24âãªããœãã¿ãã³D3ïŒ 26âããã â24âãªããœãã¿ãã³D3ïŒ 26âãã«ãªãâ1αïŒ24ïŒïŒ²ïŒâãžããããã·ã
ã¿ãã³D3ïŒ 26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âããã â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âãšãŠãâ1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âãã«ãªãâ1αïŒ24ïŒïŒ³ïŒâãžããããã·ã
ã¿ãã³D3 26âã¯ãã«â1αïŒ24ïŒïŒ³ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âããã â1αïŒ24ïŒïŒ³ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âãã«ãªãâ1αâããããã·â24âãªããœ
ãã¿ãã³D3ïŒ 26âã¯ãã«â1αâããããã·â24âãªããœã
ã¿ãã³D3ïŒ 26âããã â1αâããããã·â24âãªããœã
ã¿ãã³D3 ãªã©ãæããããã äžèšåŒãâïœãã§è¡šãããã26âããã²ã³å
ãã¿ãã³D3èªå°äœã¯ãäžèšåŒãâïœã ãåŒäžãã¯ããã²ã³ååãRâ²ã¯æ°ŽçŽ ååã
æ°Žé žåºåã¯ä¿è·ãããæ°Žé žåºãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šãããã ã§è¡šãããã26âããã²ã³åã³ã¬ã¹ã¿âïŒïŒïŒâ
ãžãšã³èªå°äœã玫å€ç·ç §å°ã次ãã§ç±ç°æ§ååå¿
ã«ä»ããå¿ èŠã«å¿ããŠè±ä¿è·ããããšã«ãã€ãŠè£œ
é ãããã åæååç©ã§ããäžèšåŒãâïœãã«ãããŠã
ã¯ããã²ã³ååãè¡šãããããã§ããã²ã³åå
ãšããŠã¯ãäžè¿°ãããã®ãšåæ§ã®ååãæããã
ãã äžèšåŒãâïœãã«ãããŠRâ²ã¯æ°ŽçŽ ååãæ°Ž
é žåºåã¯ä¿è·ãããæ°Žé žåºãè¡šãããããã§ä¿è·
ãããæ°Žé žåºã®ä¿è·åºãšããŠäžèšã®åºãæããã
ãšãã§ããã (1) ã¢ã·ã«åº äŸãã°ã¢ã»ãã«åºãããããã€ã«åºããã¿ãã€
ã«åºããã³ã¿ãã€ã«åºãã«ããã€ã«åºãã·ã¯ãã
ããµãã€ã«åºãã¯ããã¢ã»ãã«åºãããã¢ã¢ã»ã
ã«åºããã³ãŸã€ã«åºãïœâããã¢ãã³ãŸã€ã«åºã
ïœâããããã³ãŸã€ã«åºããšãã«ãã³ãŸã€ã«åºã
ãã«ã€ã«åºçã®C1ãC12ã®èèªæåã¯è³éŠæã«ã«
ãã³é žæ®åºåã¯ãããã®ããããããã²ã³ãã¢ã«
ã³ãã·çœ®æèªå°äœçã奜ãŸããçšããããã ãããã®å ãç¹ã«å¥œãŸããã¯ã¢ã»ãã«åºããã³
ãŸã€ã«åºãããããã€ã«åºçã§ããã (2) ããããã·ã«åºãšãšãŒãã«çµåã圢æããåº äŸãã°ãããªã¡ãã«ã·ãªã«åºããžã¡ãã«âïœâ
ããã«âã·ãªã«åºçã®ããªã¢ã«ãã«ã·ãªã«åºãïŒ
âããã©ããããã©ãã«åºãïŒâããã©ãããã
ã©ãã«åºçã®ïŒâç°ç¶ãšãŒãã«åºãæããããšã
ã§ããã (3) ã¢ã«ã³ãã·ã«ã«ããã«åº äŸãã°ãã¡ããã·ã«ã«ããã«åºããšããã·ã«ã«
ããã«åºãããããã·ã«ã«ããã«åºããããã·ã«
ã«ããã«åºããã³ããã·ã«ã«ããã«åºçãæãã
ããšãã§ããã äžèšä¿è·åºã®ãã¡ç¹ã«å¥œãŸããã¯ã¢ã·ã«åºãã¢
ã«ã³ãã·ã«ã«ããã«åºã§ãããããããã«éå®ã
ãããã®ã§ã¯ãªãã äžèšåŒãâïœãã«ãããŠãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šããããããä¿è·åºãšããŠã¯äžè¿°ã
ããã®ãšåæ§ã®ä¿è·åºãæããããã ãã®ãããªåæååç©ã¯ãäŸãã°ä»¥äžã«ç€ºãã
ãããã®æ¹æ³ã«ãã€ãŠåæãããã åã¯äžèšååç©ïŒãããäžèšã®æ¹æ³ã«ãã€ãŠåæ
ãããã äžèšåå¿åŒäžTSã¯ïœâãã«ãšã³ã¹ã«ããã«åº
ãè¡šãããã¯ããã²ã³ååãè¡šãããååç©ïŒã
ã®åæã¯ãç¹éæ54â41856å·å ¬å ±ãåèãšãã
ãã æ¬çºæã®è£œé æ³ã¯ãäžè¿°ããåŠãåŒãâïœã
ã®26âããã²ã³åã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³èªå°
äœã«çŽ«å€ç·ãç §å°ããããããšã«ããè¡ãããã
ããã§çŽ«å€ç·ãšã¯çŽ200ã360nmã®æ³¢é·ç¯å²ã®ã
ã®ãšããŠç¥ãããŠãããã®ã§ãããæ¬çºææ¹æ³ã§
ã¯ç¹ã«260ã310nmã®ç¯å²ã®æ³¢é·ã®ãã®ã奜ãŸã
ãçšããããã 玫å€ç·ç §å°ããã«éããŠã¯ãäžæŽ»æ§ææ©æº¶åªäž
ã§è¡ãã®ã奜ãŸããã äžæŽ»æ§ææ©æº¶åªãšããŠã¯ãäŸãã°ããããµã³ã
ããã¿ã³ãã·ã¯ããããµã³ããªã°ãã€ã³ããã³ãŒ
ã³ããã«ãšã³ããã·ã¬ã³ãããã ãã³ãŒã³ãã¯ã
ã«ãã³ãŒã³ãããããã³ãŒã³ãåå¡©åççŽ ãïŒïŒ
ïŒâãžã¯ãã«ãšã¿ã³ãïŒïŒïŒâãžããã¢ãšã¿ã³ç
ã®çåæ°ŽçŽ ãããã¯ããã²ã³åçåæ°ŽçŽ ïŒãšãŒã
ã«ãããã©ããããã©ã³ããžãªããµã³ãã¡ãã«ã»
ããŸã«ããããšãã«ã»ããŸã«ãçã®ãšãŒãã«ç³»æº¶
åªïŒã¡ã¿ããŒã«ããšã¿ããŒã«ããããããŒã«ãã
ã¿ããŒã«ããããµããŒã«ãã·ã¯ããããµããŒã«ç
ã®ã¢ã«ã³ãŒã«ç³»æº¶åªçã奜é©ãªãã®ãšããŠããçš
ããããã 玫å€ç·ç §å°ã®éã®æž©åºŠã¯â20ã80âãç¹ã«â10
ã20âã®ç¯å²ã奜é©ã§ããããŸããã¢ã«ãŽã³ãã
ãã¯çªçŽ é°å²æ°çã®é žçŽ ã®ååšããªãäžæŽ»æ§é°å²
æ°ã§è¡ãã®ã奜ãŸããã ããããŠçŽ«å€ç·ç §å°ã«ããã°åºçºåæã§ãã26
âããã²ã³åã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³èªå°äœã®
ïŒïŒ10äœãéè£ããŠ26âããã²ã³åãã¬ãã¿ãã³
D3èªå°äœãçæããããã®ãã¬ãã¿ãã³D3èªå°
äœãç±ãšãã«ã®ãŒã«ããç°æ§åããããããšã«ã
ãã26âããã²ã³åãã¿ãã³D3èªå°äœåã¯ãã®
ããããã·ä¿è·ãã¿ãã³D3èªå°äœãåŸãããã
ç°æ§ååå¿ã¯20âã120âã奜ãŸããã¯40âã100
âã§è¡ãããããã®ç°æ§ååå¿ã¯ãäžèšçŽ«å€ç·ç §
å°ã§çšããããäžæŽ»æ§ææ©æº¶åªäžã§ãã®ãŸãŸè¡ã
ããšãã§ãããããæ ãäŸãã°äžèšãã¬ãã¿ãã³
D3èªå°äœãåŸã玫å€ç·ç §å°ããäŸãã°40âã§å®
æœããå Žåã«ãããŠã¯ããã¬ãã¿ãã³D3èªå°äœ
ã®çæãšåæã«ãçæãããã¬ãã¿ãã³D3èªå°
äœãåå¿ç³»äžã«ãããŠåŸã ã«ãã¿ãã³D3èªå°äœ
ã«ç°æ§åããåå¿ãèµ·ãããšã«ãªãã æ¬çºææ¹æ³ã«ãããç±ãšãã«ã®ãŒã«ããç°æ§å
åå¿ãšã¯ãäžèšãããšããããæãããªéããå¿
ãããåå¿ç³»ã®å ç±ãæå³ãããã®ã§ã¯ãªãã ããããŠåŸãããçæç©ã¯ããã®æ°Žé žåºãä¿è·
ãããŠããå Žåã«ã¯è±ä¿è·åå¿ã«ä»ãããããã
ãè±ä¿è·åå¿ã¯çæç©ãåé¢ç²Ÿè£œããåŸã«è¡ã€ãŠ
ããããäžèšç°æ§ååå¿ã«åŒãã€ã¥ããŠè¡ã€ãŠã
ããã æ°Žé žåºã®è±ä¿è·åå¿ã¯ããèªäœå ¬ç¥ã®åå¿ã§ã
ãäŸãã°æ¬¡ã®ããã«ããŠè¡ãããšãã§ããã ä¿è·åºãã¢ã·ã«åºãŸãã¯ã¢ã«ã³ãã·ã«ã«ããã«
åºã®å Žåã«ã¯ã¡ã¿ããŒã«ããšã¿ããŒã«ã®åŠãäœçŽ
èèªæã¢ã«ã³ãŒã«ã®ã¢ã«ã«ãªæ§æº¶æ¶²äžã§åŠçãã
ããããã¯ãšãŒãã«äžLiAlH4çã®æ°ŽçŽ åéå±ã§
åŠçããã°ããã枩床ãšããŠã¯â10âã50âã§ã
ããä¿è·åºãæ°Žé žåºã®é žçŽ ååãšçµåããŠãšãŒã
ã«åºã圢æããŠããå Žåã¯ãéå çã«ãããã¯é ž
åã¯ã¢ã«ã«ãªãšæ¥è§Šããããããšã«ããã容æã«
é€å»ããããšãã§ããã ããããŠæ¬çºæã®è£œé æ³ã«ããäžèšåŒãâ
ïœãã§è¡šãããã26âããã²ã³åãã¿ãã³D3èª
å°äœãåŸãããã ãŸãåèšåŒãâïœãã§è¡šãããã26âããã²
ã³åãã¿ãã³D3èªå°äœã¯äžèšåŒãâaâ²ã ãåŒäžãã¯ããã²ã³ååãRâ²ã¯æ°ŽçŽ ååã
æ°Žé žåºåã¯ä¿è·ãããæ°Žé žåºãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šãããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœ
ãéå åå¿ã«ä»ãã次ãã§å¿ èŠã«å¿ããŠè±ä¿è·ã
ãããšã«ãã€ãŠè£œé ãããã åæååç©ã§ããäžèšåŒãâaâ²ãã«ãããŠïŒž
ã¯ããã²ã³ååãè¡šãããããã§ãããã²ã³åå
ãšããŠã¯åè¿°ãããã®ãšåæ§ã®ååãæããã
ãã äžèšåŒãâaâ²ãã«ãããŠRâ²ã¯æ°ŽçŽ ååãæ°Žé ž
åºåã¯ä¿è·ãããæ°Žé žåºãè¡šãããããã§ä¿è·ã
ããæ°Žé žåºã®ä¿è·åºãšããŠã¯åè¿°ãããã®ãšåæ§
ã®ååãæããããã äžèšåŒãâaâ²ãã«ãããŠãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šããããããä¿è·åºãšããŠã¯ãåè¿°
ãããã®ãšåæ§ã®ä¿è·åºãæããããã ãã®ãããªåæååç©ã¯ãäŸãã°åè¿°ããã
âïœãã®åææ³ãšåæ§ã®æ¹æ³ã§åæããããšãã§
ããã æ¬çºæã®è£œé æ³ã¯äžè¿°ããåŠãåŒãâaâ²ãã®
26âããã²ã³åãã¿ãã³D3èªå°äœãéå åå¿ã«
ä»ãããšã«ããè¡ãªãããã éå åå¿ã¯ããªã¬ãã€ã³åã³ããã²ã³ååã«å¯Ÿ
ãéžææ§ã®ããéå æ¡ä»¶äžã§ããã°ã©ã®æ§ãªæ¡ä»¶
ã§ãè¡ãããšãã§ãããäŸãã°ã觊åªãšããŠã¢ã«
ãããŠã ã¢ã«ã³ãã·ããçšãããã³ãã«ãéå æ¡
件ãæ°ŽçŽ åã¢ã«ãããŠã é¡ãæ°ŽçŽ åããŠçŽ é¡çã®
æ°ŽçŽ é°ã€ãªã³ãäŸäžããéå è©Šè¬ãçšããæ¡ä»¶ç
ãæããããšãã§ããããªãã§ãæ°ŽçŽ åã¢ã«ãã
ãŠã é¡ãæ°ŽçŽ åããŠçŽ é¡çã®éå è©Šè¬ãçšããæ¡
件ã奜ãŸããã æ°ŽçŽ åã¢ã«ãããŠã é¡ã®å ·äœçãªäŸãšããŠãäŸ
ãã°æ°ŽçŽ åã¢ã«ãããŠã ãªããŠã ãæ°ŽçŽ åã¢ã«ã
ããŠã ãããªãŠã ãæ°ŽçŽ åããªâïœâãããã·ã¢
ã«ãããŠã ãªããŠã ãæ°ŽçŽ åããªãšããã·ã¢ã«ã
ããŠã ãªããŠã ãæ°ŽçŽ åããªã¡ããã·ã¢ã«ãããŠ
ã ãªããŠã ãæ°ŽçŽ åãžâïœâãããã·ã¢ã«ãããŠ
ã ãªããŠã ãæ°ŽçŽ åãžãšããã·ã¢ã«ãããŠã ãªã
ãŠã ãæ°ŽçŽ åãã¹ïŒïŒâã¡ããã·ãšããã·ïŒã¢ã«
ãããŠã ãããªãŠã ãæ°ŽçŽ åããªãšããã·ã¢ã«ã
ããŠã ãããªãŠã çã奜ãŸãããã®ãšããŠæãã
ããã æ°ŽçŽ åããŠçŽ é¡ã®å ·äœçãªäŸãšããŠãäŸãã°æ°Ž
çŽ åããŠçŽ ãããªãŠã ãæ°ŽçŽ åããŠçŽ ãªããŠã ã
æ°ŽçŽ åããªãšãã«ããŠçŽ ãªããŠã ãæ°ŽçŽ åããªâ
ïœâããã«ããŠçŽ ãªããŠã ãæ°ŽçŽ åããªã¡ããã·
ããŠçŽ ãããªãŠã ãæ°ŽçŽ åããªã€ãœããããã·ã
ãŠçŽ ã«ãªãŠã çã奜ãŸãããã®ãšããŠæããã
ãã äžèšã®æ°ŽçŽ åã¢ã«ãããŠã é¡åã¯æ°ŽçŽ åããŠçŽ
é¡ã®ãã¡ãæ°ŽçŽ åã¢ã«ãããŠã ãªããŠã ãæ°ŽçŽ å
ããŠçŽ ãããªãŠã çãç¹ã«å¥œãŸããçšããããã ãããæ°ŽçŽ åã¢ã«ãããŠã é¡ãæ°ŽçŽ åããŠçŽ é¡
ã¯åæååç©ã«å¯Ÿãã0.5ãïŒåã¢ã«ã®ç¯å²ã§äœ¿
çšããã®ã奜ãŸããã åå¿ããããã«éããææ©æº¶åªã䜿çšããã®ã
æå©ã§ãããææ©æº¶åªãšããŠã¯ãžãšãã«ãšãŒã
ã«ãããã©ããããã©ã³çã®ãšãŒãã«ç³»æº¶åªïŒã¡
ãã«ã¢ã«ã³ãŒã«ããšãã«ã¢ã«ã³ãŒã«ãã€ãœããã
ã«ã¢ã«ã³ãŒã«çã®ã¢ã«ã³ãŒã«ç³»æº¶åªïŒãžã¡ãã«ã
ã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·ãçã®æº¶åªãæ
ããããã ãããææ©æº¶åªäžã«ãŠãåèš26âããã²ã³åã
ã¿ãã³D3èªå°äœãã溶解åã¯æžæ¿ããããæ¹æ
ããªããéå å€ãå°éãã€æ·»å ããæ·»å åŸæŽã«æ¹
æãè¡ããšåæ»ã«é²è¡ãããéãããã³æ§æº¶å€ã
çšãããšãã¯ãåå¿æ¶²ãæ°Žåã¯ã¢ã«ã³ãŒã«ã§åŠç
ããããšã«ããåå¿ã¯å®äºããã åå¿æž©åºŠã¯çºç±ãæå¶ããããåæã®ã¿å·åŽã
ããããããã¯å®€æž©ãå ç±æ¡ä»¶äžã§å®éçã«é²è¡
ãããåå¿æž©åºŠã®å¥œãŸããç¯å²ã¯ïŒã50âã§ã
ããåå¿ã¯æ°æéã§å®äºããã ã¢ã«ãããŠã ã¢ã«ã³ãã·ããçšãããã³ãã«ã
éå ã¯ãããèªäœå ¬ç¥ã®åå¿ã§ãããäŸãã°ã¢ã«
ãããŠã ãšããã·ããã¢ã«ãããŠã ã€ãœãããã
ã·ãçã®ã¢ã«ãããŠã ã¢ã«ã³ãã·ããçšããã¡ã¿
ããŒã«ããšã¿ããŒã«ãã€ãœãããããŒã«çã®æº¶åª
äžã§è¡ãããšãã§ããã ããããŠåŸãããçæç©ã¯ãã®æ°Žé žåºãä¿è·ã
ããŠããå Žåã«ã¯è±ä¿è·åå¿ã«ä»ããããè±ä¿è·
åå¿ã¯çæç©ãåé¢ç²Ÿè£œããåŸã«è¡ã€ãŠãããã
äžèšéå åå¿ã«åŒãã€ã¥ããŠè¡ã€ãŠããããæ°Žé ž
åºã®è±ä¿è·åå¿ã¯åè¿°ããã®ãšåæ§ã®æ¹æ³ã«ãã
è¡ãããšãã§ããã åå¿æ¶²ããç®çç©ãåé¢ç²Ÿè£œããã«ã¯ãéåžžã®
æ¹æ³ãçšãããããããªãã¡æ¿çž®ãæœåºãåçµ
æ¶ãã«ã©ã ã¯ãããã°ã©ãã€ãŒãé«é液äœã¯ãã
ãã°ã©ãã€ãŒçã®æ段ãçšããããã ããããŠæ¬çºæã®è£œé æ³ã«ããäžèšåŒãâ
ïœãã§è¡šãããã26âããã²ã³åãã¿ãã³D3èª
å°äœãåŸãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã¯è¡æž äžã®
ã«ã«ã·ãŠã ã¬ãã«ã調ç¯ããäœçšãæãããããª
ãã¡ãè žç®¡ããã®ã«ã«ã·ãŠã åžåèœãä¿é²ããè¡
äžã®ã«ã«ã·ãŠã æ¿åºŠãé«ããäœçšãæã¡ããŸã骚
塩溶解äœçšãæããã26âããã²ã³åãã¿ãã³
D3èªå°äœã®è žç®¡ããã®ã«ã«ã·ãŠã åžåèœåã³éªš
塩溶解äœçšã¯ä»ã®æŽ»æ§åãã¿ãã³D3ååç©ã«æ¯
ã¹ãŠããã®äœçšãæç¶ãããšããç¹åŸŽãæããã
åŸã€ãŠæ¬çºæã®26âããã²ã³åãã¿ãã³D3èªå°
äœã¯ãã«ã«ã·ãŠã 代è¬ç°åžžã«ãã€ãŠèµ·ããçš®ã ã®
çŸæ£ãäŸãã°éªšç²é¬çã骚è»åçãè äžå šæ£è ã®
骚ç å€çã®çŸæ£ã®æ²»çãããã¯äºé²ã«æ¥µããŠæçš
ãªãã®ã§ããã ããããŠæ¬çºæã«ããã°ãäžèšåŒããã§è¡šã
ããã26âããã²ã³åãã¿ãã³D3èªå°äœãæå¹
æåãšããã«ã«ã·ãŠã 調ç¯å€ãæäŸãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã®æäžã¯çµ
å£ãéçµå£ã®ãããã§ããããéçµå£æäžã®å Žå
ã¯çèå ãç®äžãéèå ãçŽè žæäžçãããããª
ãã§ãçµå£æäžã奜ãŸãããæ¬ååç©ã掻æ§æå
ãšããã«ã«ã·ãŠã 調ç¯å€ã¯é å€ãæ£å€ãé¡ç²å€ã
åå€ãã«ãã»ã«å€ãã¢ã«ã³ãŒã«æº¶æ¶²å€ãæ²¹æ§æº¶æ¶²
å€ãæ°Žæ§æžæ¿å€ãªã©ã®æäžåœ¢æ ã§çšããããã é å€ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãäŸãã°ä¹³
ç³ããã³ãã³ãçé žã«ã«ã·ãŠã ãçµæ¶ã»ã«ããŒ
ã¹ãã±ã€é žãªã©ã®è³Šåœ¢å€ïŒã«ã«ããã·ã¡ãã«ã»ã«
ããŒã¹ãã¡ãã«ã»ã«ããŒã¹ããªã³é žã«ãªãŠã ãã
ãªããã«ãããªãã³ãªã©ã®çµåå€ïŒã¢ã«ã®ã³é žã
ããªãŠã ãçé žæ°ŽçŽ ãããªãŠã ãã©ãŠãªã«ç¡«é žã
ããªãŠã ãã¹ãã¢ãªã³é žã¢ãã°ãªã»ã©ã€ããªã©ã®
厩å£å€ïŒã°ãªã»ãªã³ãªã©ã®ä¿æ¹¿å€ïŒã«ãªãªã³ãã³
ãã€ãç¶ã±ã€é žãªã©ã®åžçå€ïŒç²Ÿè£œã¿ã«ã¯ãããŠ
é žæ«ãªã©ã®æ»æ²¢å€çãçšããŠéåžžã®æ¹æ³ã«ããæ
圢ããããšãã§ãããæ£å€ãé¡ç²å€ããåæ§ã«äž
èšã®è³Šåœ¢å€çãçšããŠéåžžã®æ¹æ³ã«ãã€ãŠæ圢ã
ãããšãã§ãããåå€ã®åœ¢æ ã«æ圢ããã«éããŠ
ã¯ãäŸãã°ããªãšãã¬ã³ã°ãªã³ãŒã«ãã«ã«ãªèã
é«çŽã¢ã«ã³ãŒã«ããŒã©ãã³ãªã©ãçšããŠåŸæ¥å ¬ç¥
ã®æ¹æ³ã«ããæ圢ããããšãã§ããã ã«ãã»ã«å€ã¯æ¬ååç©ã®æ²¹æ§æº¶æ¶²ãçšããŠè»ã«
ãã»ã«å€çã«ããããšã«ãã€ãŠåŸããããæ²¹æ§æº¶
液ã®æº¶åªãšããŠã¯æ€ç©æ²¹ãããšãã°ããŠã¢ãã³ã·
æ²¹ãæ£å®æ²¹ãã³ã³ãããæ²¹ãã¢ãŒã¢ã³ãæ²¹ãèœäž
çæ²¹ãéèæ²¹ãæ²¹ç¶ãšã¹ãã«ãªã©ã䜿çšããããš
ãã§ããã ã¢ã«ã³ãŒã«æº¶æ¶²å€ãæ²¹æ§æº¶æ¶²å€ãæ°Žæ§æžæ¿å€ãª
ã©ã¯å ¬ç¥ã®æ¹æ³ã«ãã€ãŠåŸãããšãã§ããã æ¬ååç©ã®ä¿å寿åœã延é·ããããã«ã補å€äž
ã«ãæé žåå€ãäŸãã°ã¢ã¹ã³ã«ãã³é žãããã«å
ããããã·ã¢ããœãŒã«ããããããã³ãªã©ãæ··å ¥
ããããšã§ãã§ããã æ¬çºæã®26âããã²ã³åãã¿ãã³D3èªå°äœã®
æäžéã¯ãæ£è ã®å¹Žéœ¢ãæ§å¥ãçŸæ£ã®çšåºŠãªã©ã«
ããé©å®éžæãããããéåžžïŒã200nïœïŒKgïŒ
æ¥ããã奜ãŸããã¯ïŒã40nïœïŒKgïŒæ¥ã§ããã
ãããæäžéãããåäœæäžåœ¢æ ã«ãã補å€ã«å«
æãããã26âããã²ã³åãã¿ãã³D3èªå°äœã®
éã決å®ãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã¯ããã骚
é«æ§çœè¡ç 现èã§ããHLâ60现èïŒããããã
ãšããµã€ãïŒã®é¡ç²çããã¯ããã¢ãŒãžãžã®åå
èªå°èœãæãããŸãå°è žã®cytosolç»åäžã®ãªã»
ãã¿ãŒèçœã«å¯Ÿããçµåèœãæããã26âããã²
ã³åãã¿ãã³D3èªå°äœã¯ã骚é«æ§çœè¡ç ã骚é«
å¢æ®çãçæ£å€è¡ççã«ãç¹ã«éªšé«æ§çœè¡ç ã«æ
å¹ã§ããã ãããã€ãŠæ¬çºæã«ããã°ãäžèšåŒããã§è¡š
ãããã26âããã²ã³åãã¿ãã³D3èªå°äœãæ
å¹æåãšããè±è «çå€ãæäŸãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã®æäžã¯çµ
å£ã»éçµå£ã®ãããã§ããããéçµå£æäžã®å Žå
ã¯èŒžæ¶²çšæ³šå°å€ã泚å°å€çã®å€åã§éèå ãçè
å ãç®å ãããã¯è ¹è å æäžãããçµå£æäžã®å Ž
åã¯ãŒã©ãã³ãœããã«ãã»ã«å€ãé å€ãäžžå€ãé¡
ç²å€çã®å€åã§æäžãããããªãã§ãæ¬çºæã®è±
è «çå€ã«ãããŠã¯æŽ»æ§æåã§ãã26âããã²ã³å
ãã¿ãã³D3èªå°äœã®å«æéãã骚ç å€çã®æ²»ç
å€ã«äœ¿çšããå Žåã«æ¯ããŠãæ¯èŒçå€ãããå¿ èŠ
ã®ããããšãããå€åãšããŠã¯ãŒã©ãã³ãœããã«
ãã»ã«å€ã茞液çšæ³šå°å€ãç¹ã«å¥œãŸããã ãŒã©ãã³ãœããã«ãã»ã«å€ãšããŠã¯ããŒã©ã
ã³ãã°ãªã»ãªã³çã®é垞䜿çšãããçµæã§å€ç®ã
圢æãã26âããã²ã³åãã¿ãã³D3èªå°äœãè
èªé žã®ã°ãªã»ãªãé¡ãã³ã³ãããæ²¹ãã³ãŒã³ãªã€
ã«ããªãªãŒãæ²¹ããŽãæ²¹çã®æ²¹ç¶ã®èèªæ²¹ã«æº¶è§£
ããããŠããããå€ç®äžã«å å¡«ããããããšã«ã
ã€ãŠåŸããããã®ã奜ãŸãããæ¬çºæã®26âãã
ã²ã³åãã¿ãã³D3èªå°äœãè±è «çå€ãšããŠæäž
ãããšãã®æäžéã¯éåžžïŒã400nïœïŒKgïŒæ¥ã
ãã奜ãŸããã¯ïŒã100nïœïŒKgïŒæ¥ã§ãããã
ããã€ãŠïŒã«ãã»ã«äžã«å«æãããã26âããã²
ã³åãã¿ãã³D3èªå°äœã®éã¯ãè±è «çå€ãšããŠ
ã®å¹æãæäžã®åæ°çãèæ ®ããŠ0.1ã20ÎŒïœãç¹
ã«å¥œãŸããã¯0.25ã5ÎŒïœã§ããã 茞液çšæ³šå°å€ãšããŠã¯26âããã²ã³åãã¿ãã³
D3èªå°äœããªãªãŒãæ²¹ããŽãæ²¹ããã€ãºæ²¹ãã¡
ã³ãžãæ²¹çã®æ€ç©æ²¹ã§ããé氎溶æ§å€ããããã¯
ççé£å¡©æ¶²ããªã³ã²ã«æ¶²ã泚å°çšèžçæ°Žçã®æ°Žæ§
溶å€ã«é©åœãªæº¶è§£è£å©å€ãšãšãã«æº¶è§£ããããã
殺èããŠèŒžæ¶²çšæ³šå°å€ã«éåžžçšããããŠããã¬ã©
ã¹å®¹åšããã©ã¹ããã¯å®¹åšçã«å å¡«ããããããš
ã«ãã€ãŠåŸãããšãã§ããããã®ãããªèŒžæ¶²çšæ³š
å°å€äžã«å«æãã26âããã²ã³åãã¿ãã³D3èª
å°äœã®éã¯0.1ã20ÎŒïœãç¹ã«å¥œãŸããã¯0.5ã10ÎŒ
ïœã§ããã 以äžã«æ¬çºæãå®æœäŸã«ããæŽã«è©³çŽ°ã«èª¬æã
ãã åèäŸ ïŒ 24âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒ
ïŒâãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â1αïŒ3β
âãžãªãŒã«ïŒïŒãïŒã®åæ 24âãªããœã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³â1αïŒ
3βâãžãªãŒã«6.0ïœãããã©ããããã©ã³âå¡©å
ã¡ãã¬ã³ïŒïŒïŒïŒïŒ200mlã«æº¶è§£ããïŒâããšã
ã«âïŒïŒïŒïŒïŒâããªã¢ãŸãªã³âïŒïŒïŒâãžãªã³
ã®ã¢ã»ãã³æº¶æ¶²ãåå¿æ¶²ã®èµ€è²ãæ¶ããªããªããŸ
ã§æ»ŽäžãããïŒæéæ¹æããåŸãæžå§äžæº¶åªãæ¿
çž®ããåŸãããç²çæç©ãã·ãªã«ã²ã«ã«ã©ã ïŒæº¶
åªïŒãã³ãŒã³âã¢ã»ãã³ç³»ïŒã«ä»ãããšã«ããã
24âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒ
âãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â1αïŒ3βâãž
ãªãŒã«7.7ïœãåŸãããã®ãã®ã®ç©æ§å€ã¯æ¬¡ã®é
ãã§ãã€ãã MSïŒïœïŒïœ ïŒïŒ
ã26âããã²ã³åãã¿ãã³D3èªå°äœãã®è£œé æ³
åã³ãããæå¹æåãšããè¬å€ã«é¢ãããæŽã«è©³
现ã«ã¯ãæ¬çºæã¯åªããè¬çäœçšãããªãã¡è žç®¡
ããã®ã«ã«ã·ãŠã åžåèœãä¿é²ããŠè¡äžã®ã«ã«ã·
ãŠã æ¿åºŠãé«ããäœçšåã³éªšå¡©æº¶è§£äœçšãæããŸ
ããããã®è¬çäœçšã®æç¶æéãé·ããããæ ã«
ã«ã«ã·ãŠã 代è¬ç°åžžã«ããèµ·ããçš®ã ã®çŸæ£ãäŸ
ãã°éªšç²é¬çã骚è»åçãªã©ã®éªšç å€çã®æ²»çã
ããã¯äºé²è¬ãšããŠæçšã§ããããããã¯ãŸãäŸ
ãã°ãã骚é«æ§çœè¡ç 现èãæ£åžžçŽ°èã«ååèªå°
ããäœçšãæããè±è «çå€ãšããŠãæçšãª26âã
ãã²ã³åãã¿ãã³D3èªå°äœãã®è£œé æ³åã³ãã
ãæå¹æåãšããè¬å€ã«é¢ããã åŸæ¥æè¡ æŽ»æ§åãã¿ãã³D3ãšããŠã1αïŒ25âãžããã
ãã·ãã¿ãã³D3ã1αïŒ24âãžããããã·ãã¿ã
ã³D3ïŒ1αâããããã·â24âãªããœãã¿ãã³D3ïŒ
24ïŒ24âãžãã«ãªãâ1αïŒ25âãžããããã·ã
ã¿ãã³D3ãªã©ãç¥ãããŠããããããã®ååç©
ã¯ãçäœå ã®ã«ã«ã·ãŠã ã¬ãã«ã調ç¯ãã骚ç²é¬
çã骚è»åçãªã©ã®ãããã骚æžå°çã«æçšã§ã
ãããšãç¥ãããŠãããU.S.Patent No.
4022891ïŒVitamin ïŒBasic Research and
itsclinical ApplicationïŒ1099ã1106ïŒ1979ïŒãã
ãŸ
ããããã®ååç©ã¯ããã骚é«æ§çœè¡ç 现èã®ã
ã¯ããã¢ãŒãžãé¡ç²çãžã®ååèªå°èœãæãè±è «
çå€ãšããŠãæçšã§ããããšãç¥ãããŠãã
ïŒProc.Natl.Acad.Sci.USAïŒVol.78ïŒNo.ïŒïŒ
pp.4990ã4994ïŒ1981ïŒïŒç¹éæ58â149224å·å ¬å ±ã
ç¹éæ57â149224å·å ¬å ±ïŒã ããããªããã24äœã«ãªããœåºãããã¯æ°Žé žåº
ãæãããã€26äœã«ããã²ã³ååãæãã26âã
ãã²ã³åãã¿ãã³D3èªå°äœã¯æç®æªèŒã®æ°èŠå
åç©ã§ããããã®è£œé æ³ãè¬ç掻æ§çã«ã€ããŠã¯
åŸæ¥å šãç¥ãããŠããªãã çºæã®ç®ç æ¬çºæã®ç®çã¯ãæ°èŠååç©ã§ãã€ãŠãåªãã
è¬çäœçšãæãã26âããã²ã³åãã¿ãã³D3èª
å°äœãã®è£œé æ³åã³ãããæå¹æåãšããè¬å€ã
æäŸããããšã«ããã çºæã®æ§æåã³å¹æ æ¬çºæã§æäŸããã26âããã²ã³åãã¿ãã³
D3èªå°äœã¯äžèšåŒãã ãåŒäžãã¯ããã²ã³ååãã¯ããããã·ã¡
ãã¬ã³åºåã¯ã«ã«ããã«åºãã¯æ°ŽçŽ åååã¯æ°Ž
é žåºãè¡šãããã ã§è¡šããããã äžèšåŒããã®26âããã²ã³åãã¿ãã³D3èª
å°äœã¯ã24äœã«ãªããœåºåã¯æ°Žé žåºãæãããã€
26äœã«ããã²ã³ååãæãããã®ã§ãããåŸæ¥å š
ãç¥ãããŠããªãæ§é ãæã€ãŠããã äžèšåŒããã«ãããŠïŒžã¯ããã²ã³ååãè¡šã
ããããã§ããã²ã³ååãšããŠã¯ãããçŽ ãå¡©
çŽ ãèçŽ ããšãŠçŽ ååãæããããšãã§ããã
ã¯ããããã·ã¡ãã¬ã³åºåã¯ã«ã«ããã«åºãè¡šã
ããã¯æ°ŽçŽ åååã¯æ°Žé žåºãè¡šããã ã®å®çŸ©ããäžèšåŒããã®ååç©ã¯æ¬¡ã®åå
ç©ã«åããããã ãããããã·ã¡ãã¬ã³åºã§ãããšããæ¬çºæ
ã®26âããã²ã³åãã¿ãã³D3èªå°äœã¯äžèšåŒ
ãâïœã ãåŒäžãïŒïŒ²ã¯äžèšå®çŸ©ã«åããã ã§è¡šããããååç©ã§ããããã«ã«ããã«åºã§
ãããšãæ¬çºæã®26âããã²ã³åãã¿ãã³D3èª
å°äœã¯äžèšåŒãâïœã ãåŒäžãïŒïŒ²ã¯äžèšå®çŸ©ã«åãã ã§è¡šããããååç©ã§ããã æ¬çºæã®26âããã²ã³åãã¿ãã³D3èªå°äœã®
å ·äœäŸãšããŠã¯æ¬¡ã®ãã®ãæããããã 26âãã«ãªãâ24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âã¯ãã«â24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âããã â24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âãšãŠãâ24ïŒïŒ²ïŒâããããã·ãã¿ãã³
D3ïŒ 26âãã«ãªãâ24ïŒïŒ³ïŒâããããã·ãã¿ãã³
D3ïŒ 26âã¯ãã«â24ïŒïŒ³ïŒâããããã·ãã¿ãã³
D3ïŒ 26âããã â24ïŒïŒ³ïŒâããããã·ãã¿ãã³
D3ïŒ 26âãã«ãªãâ24âãªããœãã¿ãã³D3ïŒ 26âã¯ãã«â24âãªããœãã¿ãã³D3ïŒ 26âããã â24âãªããœãã¿ãã³D3ïŒ 26âãã«ãªãâ1αïŒ24ïŒïŒ²ïŒâãžããããã·ã
ã¿ãã³D3ïŒ 26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âããã â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âãšãŠãâ1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âãã«ãªãâ1αïŒ24ïŒïŒ³ïŒâãžããããã·ã
ã¿ãã³D3 26âã¯ãã«â1αïŒ24ïŒïŒ³ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âããã â1αïŒ24ïŒïŒ³ïŒâãžããããã·ãã¿
ãã³D3ïŒ 26âãã«ãªãâ1αâããããã·â24âãªããœ
ãã¿ãã³D3ïŒ 26âã¯ãã«â1αâããããã·â24âãªããœã
ã¿ãã³D3ïŒ 26âããã â1αâããããã·â24âãªããœã
ã¿ãã³D3 ãªã©ãæããããã äžèšåŒãâïœãã§è¡šãããã26âããã²ã³å
ãã¿ãã³D3èªå°äœã¯ãäžèšåŒãâïœã ãåŒäžãã¯ããã²ã³ååãRâ²ã¯æ°ŽçŽ ååã
æ°Žé žåºåã¯ä¿è·ãããæ°Žé žåºãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šãããã ã§è¡šãããã26âããã²ã³åã³ã¬ã¹ã¿âïŒïŒïŒâ
ãžãšã³èªå°äœã玫å€ç·ç §å°ã次ãã§ç±ç°æ§ååå¿
ã«ä»ããå¿ èŠã«å¿ããŠè±ä¿è·ããããšã«ãã€ãŠè£œ
é ãããã åæååç©ã§ããäžèšåŒãâïœãã«ãããŠã
ã¯ããã²ã³ååãè¡šãããããã§ããã²ã³åå
ãšããŠã¯ãäžè¿°ãããã®ãšåæ§ã®ååãæããã
ãã äžèšåŒãâïœãã«ãããŠRâ²ã¯æ°ŽçŽ ååãæ°Ž
é žåºåã¯ä¿è·ãããæ°Žé žåºãè¡šãããããã§ä¿è·
ãããæ°Žé žåºã®ä¿è·åºãšããŠäžèšã®åºãæããã
ãšãã§ããã (1) ã¢ã·ã«åº äŸãã°ã¢ã»ãã«åºãããããã€ã«åºããã¿ãã€
ã«åºããã³ã¿ãã€ã«åºãã«ããã€ã«åºãã·ã¯ãã
ããµãã€ã«åºãã¯ããã¢ã»ãã«åºãããã¢ã¢ã»ã
ã«åºããã³ãŸã€ã«åºãïœâããã¢ãã³ãŸã€ã«åºã
ïœâããããã³ãŸã€ã«åºããšãã«ãã³ãŸã€ã«åºã
ãã«ã€ã«åºçã®C1ãC12ã®èèªæåã¯è³éŠæã«ã«
ãã³é žæ®åºåã¯ãããã®ããããããã²ã³ãã¢ã«
ã³ãã·çœ®æèªå°äœçã奜ãŸããçšããããã ãããã®å ãç¹ã«å¥œãŸããã¯ã¢ã»ãã«åºããã³
ãŸã€ã«åºãããããã€ã«åºçã§ããã (2) ããããã·ã«åºãšãšãŒãã«çµåã圢æããåº äŸãã°ãããªã¡ãã«ã·ãªã«åºããžã¡ãã«âïœâ
ããã«âã·ãªã«åºçã®ããªã¢ã«ãã«ã·ãªã«åºãïŒ
âããã©ããããã©ãã«åºãïŒâããã©ãããã
ã©ãã«åºçã®ïŒâç°ç¶ãšãŒãã«åºãæããããšã
ã§ããã (3) ã¢ã«ã³ãã·ã«ã«ããã«åº äŸãã°ãã¡ããã·ã«ã«ããã«åºããšããã·ã«ã«
ããã«åºãããããã·ã«ã«ããã«åºããããã·ã«
ã«ããã«åºããã³ããã·ã«ã«ããã«åºçãæãã
ããšãã§ããã äžèšä¿è·åºã®ãã¡ç¹ã«å¥œãŸããã¯ã¢ã·ã«åºãã¢
ã«ã³ãã·ã«ã«ããã«åºã§ãããããããã«éå®ã
ãããã®ã§ã¯ãªãã äžèšåŒãâïœãã«ãããŠãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šããããããä¿è·åºãšããŠã¯äžè¿°ã
ããã®ãšåæ§ã®ä¿è·åºãæããããã ãã®ãããªåæååç©ã¯ãäŸãã°ä»¥äžã«ç€ºãã
ãããã®æ¹æ³ã«ãã€ãŠåæãããã åã¯äžèšååç©ïŒãããäžèšã®æ¹æ³ã«ãã€ãŠåæ
ãããã äžèšåå¿åŒäžTSã¯ïœâãã«ãšã³ã¹ã«ããã«åº
ãè¡šãããã¯ããã²ã³ååãè¡šãããååç©ïŒã
ã®åæã¯ãç¹éæ54â41856å·å ¬å ±ãåèãšãã
ãã æ¬çºæã®è£œé æ³ã¯ãäžè¿°ããåŠãåŒãâïœã
ã®26âããã²ã³åã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³èªå°
äœã«çŽ«å€ç·ãç §å°ããããããšã«ããè¡ãããã
ããã§çŽ«å€ç·ãšã¯çŽ200ã360nmã®æ³¢é·ç¯å²ã®ã
ã®ãšããŠç¥ãããŠãããã®ã§ãããæ¬çºææ¹æ³ã§
ã¯ç¹ã«260ã310nmã®ç¯å²ã®æ³¢é·ã®ãã®ã奜ãŸã
ãçšããããã 玫å€ç·ç §å°ããã«éããŠã¯ãäžæŽ»æ§ææ©æº¶åªäž
ã§è¡ãã®ã奜ãŸããã äžæŽ»æ§ææ©æº¶åªãšããŠã¯ãäŸãã°ããããµã³ã
ããã¿ã³ãã·ã¯ããããµã³ããªã°ãã€ã³ããã³ãŒ
ã³ããã«ãšã³ããã·ã¬ã³ãããã ãã³ãŒã³ãã¯ã
ã«ãã³ãŒã³ãããããã³ãŒã³ãåå¡©åççŽ ãïŒïŒ
ïŒâãžã¯ãã«ãšã¿ã³ãïŒïŒïŒâãžããã¢ãšã¿ã³ç
ã®çåæ°ŽçŽ ãããã¯ããã²ã³åçåæ°ŽçŽ ïŒãšãŒã
ã«ãããã©ããããã©ã³ããžãªããµã³ãã¡ãã«ã»
ããŸã«ããããšãã«ã»ããŸã«ãçã®ãšãŒãã«ç³»æº¶
åªïŒã¡ã¿ããŒã«ããšã¿ããŒã«ããããããŒã«ãã
ã¿ããŒã«ããããµããŒã«ãã·ã¯ããããµããŒã«ç
ã®ã¢ã«ã³ãŒã«ç³»æº¶åªçã奜é©ãªãã®ãšããŠããçš
ããããã 玫å€ç·ç §å°ã®éã®æž©åºŠã¯â20ã80âãç¹ã«â10
ã20âã®ç¯å²ã奜é©ã§ããããŸããã¢ã«ãŽã³ãã
ãã¯çªçŽ é°å²æ°çã®é žçŽ ã®ååšããªãäžæŽ»æ§é°å²
æ°ã§è¡ãã®ã奜ãŸããã ããããŠçŽ«å€ç·ç §å°ã«ããã°åºçºåæã§ãã26
âããã²ã³åã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³èªå°äœã®
ïŒïŒ10äœãéè£ããŠ26âããã²ã³åãã¬ãã¿ãã³
D3èªå°äœãçæããããã®ãã¬ãã¿ãã³D3èªå°
äœãç±ãšãã«ã®ãŒã«ããç°æ§åããããããšã«ã
ãã26âããã²ã³åãã¿ãã³D3èªå°äœåã¯ãã®
ããããã·ä¿è·ãã¿ãã³D3èªå°äœãåŸãããã
ç°æ§ååå¿ã¯20âã120âã奜ãŸããã¯40âã100
âã§è¡ãããããã®ç°æ§ååå¿ã¯ãäžèšçŽ«å€ç·ç §
å°ã§çšããããäžæŽ»æ§ææ©æº¶åªäžã§ãã®ãŸãŸè¡ã
ããšãã§ãããããæ ãäŸãã°äžèšãã¬ãã¿ãã³
D3èªå°äœãåŸã玫å€ç·ç §å°ããäŸãã°40âã§å®
æœããå Žåã«ãããŠã¯ããã¬ãã¿ãã³D3èªå°äœ
ã®çæãšåæã«ãçæãããã¬ãã¿ãã³D3èªå°
äœãåå¿ç³»äžã«ãããŠåŸã ã«ãã¿ãã³D3èªå°äœ
ã«ç°æ§åããåå¿ãèµ·ãããšã«ãªãã æ¬çºææ¹æ³ã«ãããç±ãšãã«ã®ãŒã«ããç°æ§å
åå¿ãšã¯ãäžèšãããšããããæãããªéããå¿
ãããåå¿ç³»ã®å ç±ãæå³ãããã®ã§ã¯ãªãã ããããŠåŸãããçæç©ã¯ããã®æ°Žé žåºãä¿è·
ãããŠããå Žåã«ã¯è±ä¿è·åå¿ã«ä»ãããããã
ãè±ä¿è·åå¿ã¯çæç©ãåé¢ç²Ÿè£œããåŸã«è¡ã€ãŠ
ããããäžèšç°æ§ååå¿ã«åŒãã€ã¥ããŠè¡ã€ãŠã
ããã æ°Žé žåºã®è±ä¿è·åå¿ã¯ããèªäœå ¬ç¥ã®åå¿ã§ã
ãäŸãã°æ¬¡ã®ããã«ããŠè¡ãããšãã§ããã ä¿è·åºãã¢ã·ã«åºãŸãã¯ã¢ã«ã³ãã·ã«ã«ããã«
åºã®å Žåã«ã¯ã¡ã¿ããŒã«ããšã¿ããŒã«ã®åŠãäœçŽ
èèªæã¢ã«ã³ãŒã«ã®ã¢ã«ã«ãªæ§æº¶æ¶²äžã§åŠçãã
ããããã¯ãšãŒãã«äžLiAlH4çã®æ°ŽçŽ åéå±ã§
åŠçããã°ããã枩床ãšããŠã¯â10âã50âã§ã
ããä¿è·åºãæ°Žé žåºã®é žçŽ ååãšçµåããŠãšãŒã
ã«åºã圢æããŠããå Žåã¯ãéå çã«ãããã¯é ž
åã¯ã¢ã«ã«ãªãšæ¥è§Šããããããšã«ããã容æã«
é€å»ããããšãã§ããã ããããŠæ¬çºæã®è£œé æ³ã«ããäžèšåŒãâ
ïœãã§è¡šãããã26âããã²ã³åãã¿ãã³D3èª
å°äœãåŸãããã ãŸãåèšåŒãâïœãã§è¡šãããã26âããã²
ã³åãã¿ãã³D3èªå°äœã¯äžèšåŒãâaâ²ã ãåŒäžãã¯ããã²ã³ååãRâ²ã¯æ°ŽçŽ ååã
æ°Žé žåºåã¯ä¿è·ãããæ°Žé žåºãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šãããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœ
ãéå åå¿ã«ä»ãã次ãã§å¿ èŠã«å¿ããŠè±ä¿è·ã
ãããšã«ãã€ãŠè£œé ãããã åæååç©ã§ããäžèšåŒãâaâ²ãã«ãããŠïŒž
ã¯ããã²ã³ååãè¡šãããããã§ãããã²ã³åå
ãšããŠã¯åè¿°ãããã®ãšåæ§ã®ååãæããã
ãã äžèšåŒãâaâ²ãã«ãããŠRâ²ã¯æ°ŽçŽ ååãæ°Žé ž
åºåã¯ä¿è·ãããæ°Žé žåºãè¡šãããããã§ä¿è·ã
ããæ°Žé žåºã®ä¿è·åºãšããŠã¯åè¿°ãããã®ãšåæ§
ã®ååãæããããã äžèšåŒãâaâ²ãã«ãããŠãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šããããããä¿è·åºãšããŠã¯ãåè¿°
ãããã®ãšåæ§ã®ä¿è·åºãæããããã ãã®ãããªåæååç©ã¯ãäŸãã°åè¿°ããã
âïœãã®åææ³ãšåæ§ã®æ¹æ³ã§åæããããšãã§
ããã æ¬çºæã®è£œé æ³ã¯äžè¿°ããåŠãåŒãâaâ²ãã®
26âããã²ã³åãã¿ãã³D3èªå°äœãéå åå¿ã«
ä»ãããšã«ããè¡ãªãããã éå åå¿ã¯ããªã¬ãã€ã³åã³ããã²ã³ååã«å¯Ÿ
ãéžææ§ã®ããéå æ¡ä»¶äžã§ããã°ã©ã®æ§ãªæ¡ä»¶
ã§ãè¡ãããšãã§ãããäŸãã°ã觊åªãšããŠã¢ã«
ãããŠã ã¢ã«ã³ãã·ããçšãããã³ãã«ãéå æ¡
件ãæ°ŽçŽ åã¢ã«ãããŠã é¡ãæ°ŽçŽ åããŠçŽ é¡çã®
æ°ŽçŽ é°ã€ãªã³ãäŸäžããéå è©Šè¬ãçšããæ¡ä»¶ç
ãæããããšãã§ããããªãã§ãæ°ŽçŽ åã¢ã«ãã
ãŠã é¡ãæ°ŽçŽ åããŠçŽ é¡çã®éå è©Šè¬ãçšããæ¡
件ã奜ãŸããã æ°ŽçŽ åã¢ã«ãããŠã é¡ã®å ·äœçãªäŸãšããŠãäŸ
ãã°æ°ŽçŽ åã¢ã«ãããŠã ãªããŠã ãæ°ŽçŽ åã¢ã«ã
ããŠã ãããªãŠã ãæ°ŽçŽ åããªâïœâãããã·ã¢
ã«ãããŠã ãªããŠã ãæ°ŽçŽ åããªãšããã·ã¢ã«ã
ããŠã ãªããŠã ãæ°ŽçŽ åããªã¡ããã·ã¢ã«ãããŠ
ã ãªããŠã ãæ°ŽçŽ åãžâïœâãããã·ã¢ã«ãããŠ
ã ãªããŠã ãæ°ŽçŽ åãžãšããã·ã¢ã«ãããŠã ãªã
ãŠã ãæ°ŽçŽ åãã¹ïŒïŒâã¡ããã·ãšããã·ïŒã¢ã«
ãããŠã ãããªãŠã ãæ°ŽçŽ åããªãšããã·ã¢ã«ã
ããŠã ãããªãŠã çã奜ãŸãããã®ãšããŠæãã
ããã æ°ŽçŽ åããŠçŽ é¡ã®å ·äœçãªäŸãšããŠãäŸãã°æ°Ž
çŽ åããŠçŽ ãããªãŠã ãæ°ŽçŽ åããŠçŽ ãªããŠã ã
æ°ŽçŽ åããªãšãã«ããŠçŽ ãªããŠã ãæ°ŽçŽ åããªâ
ïœâããã«ããŠçŽ ãªããŠã ãæ°ŽçŽ åããªã¡ããã·
ããŠçŽ ãããªãŠã ãæ°ŽçŽ åããªã€ãœããããã·ã
ãŠçŽ ã«ãªãŠã çã奜ãŸãããã®ãšããŠæããã
ãã äžèšã®æ°ŽçŽ åã¢ã«ãããŠã é¡åã¯æ°ŽçŽ åããŠçŽ
é¡ã®ãã¡ãæ°ŽçŽ åã¢ã«ãããŠã ãªããŠã ãæ°ŽçŽ å
ããŠçŽ ãããªãŠã çãç¹ã«å¥œãŸããçšããããã ãããæ°ŽçŽ åã¢ã«ãããŠã é¡ãæ°ŽçŽ åããŠçŽ é¡
ã¯åæååç©ã«å¯Ÿãã0.5ãïŒåã¢ã«ã®ç¯å²ã§äœ¿
çšããã®ã奜ãŸããã åå¿ããããã«éããææ©æº¶åªã䜿çšããã®ã
æå©ã§ãããææ©æº¶åªãšããŠã¯ãžãšãã«ãšãŒã
ã«ãããã©ããããã©ã³çã®ãšãŒãã«ç³»æº¶åªïŒã¡
ãã«ã¢ã«ã³ãŒã«ããšãã«ã¢ã«ã³ãŒã«ãã€ãœããã
ã«ã¢ã«ã³ãŒã«çã®ã¢ã«ã³ãŒã«ç³»æº¶åªïŒãžã¡ãã«ã
ã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·ãçã®æº¶åªãæ
ããããã ãããææ©æº¶åªäžã«ãŠãåèš26âããã²ã³åã
ã¿ãã³D3èªå°äœãã溶解åã¯æžæ¿ããããæ¹æ
ããªããéå å€ãå°éãã€æ·»å ããæ·»å åŸæŽã«æ¹
æãè¡ããšåæ»ã«é²è¡ãããéãããã³æ§æº¶å€ã
çšãããšãã¯ãåå¿æ¶²ãæ°Žåã¯ã¢ã«ã³ãŒã«ã§åŠç
ããããšã«ããåå¿ã¯å®äºããã åå¿æž©åºŠã¯çºç±ãæå¶ããããåæã®ã¿å·åŽã
ããããããã¯å®€æž©ãå ç±æ¡ä»¶äžã§å®éçã«é²è¡
ãããåå¿æž©åºŠã®å¥œãŸããç¯å²ã¯ïŒã50âã§ã
ããåå¿ã¯æ°æéã§å®äºããã ã¢ã«ãããŠã ã¢ã«ã³ãã·ããçšãããã³ãã«ã
éå ã¯ãããèªäœå ¬ç¥ã®åå¿ã§ãããäŸãã°ã¢ã«
ãããŠã ãšããã·ããã¢ã«ãããŠã ã€ãœãããã
ã·ãçã®ã¢ã«ãããŠã ã¢ã«ã³ãã·ããçšããã¡ã¿
ããŒã«ããšã¿ããŒã«ãã€ãœãããããŒã«çã®æº¶åª
äžã§è¡ãããšãã§ããã ããããŠåŸãããçæç©ã¯ãã®æ°Žé žåºãä¿è·ã
ããŠããå Žåã«ã¯è±ä¿è·åå¿ã«ä»ããããè±ä¿è·
åå¿ã¯çæç©ãåé¢ç²Ÿè£œããåŸã«è¡ã€ãŠãããã
äžèšéå åå¿ã«åŒãã€ã¥ããŠè¡ã€ãŠããããæ°Žé ž
åºã®è±ä¿è·åå¿ã¯åè¿°ããã®ãšåæ§ã®æ¹æ³ã«ãã
è¡ãããšãã§ããã åå¿æ¶²ããç®çç©ãåé¢ç²Ÿè£œããã«ã¯ãéåžžã®
æ¹æ³ãçšãããããããªãã¡æ¿çž®ãæœåºãåçµ
æ¶ãã«ã©ã ã¯ãããã°ã©ãã€ãŒãé«é液äœã¯ãã
ãã°ã©ãã€ãŒçã®æ段ãçšããããã ããããŠæ¬çºæã®è£œé æ³ã«ããäžèšåŒãâ
ïœãã§è¡šãããã26âããã²ã³åãã¿ãã³D3èª
å°äœãåŸãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã¯è¡æž äžã®
ã«ã«ã·ãŠã ã¬ãã«ã調ç¯ããäœçšãæãããããª
ãã¡ãè žç®¡ããã®ã«ã«ã·ãŠã åžåèœãä¿é²ããè¡
äžã®ã«ã«ã·ãŠã æ¿åºŠãé«ããäœçšãæã¡ããŸã骚
塩溶解äœçšãæããã26âããã²ã³åãã¿ãã³
D3èªå°äœã®è žç®¡ããã®ã«ã«ã·ãŠã åžåèœåã³éªš
塩溶解äœçšã¯ä»ã®æŽ»æ§åãã¿ãã³D3ååç©ã«æ¯
ã¹ãŠããã®äœçšãæç¶ãããšããç¹åŸŽãæããã
åŸã€ãŠæ¬çºæã®26âããã²ã³åãã¿ãã³D3èªå°
äœã¯ãã«ã«ã·ãŠã 代è¬ç°åžžã«ãã€ãŠèµ·ããçš®ã ã®
çŸæ£ãäŸãã°éªšç²é¬çã骚è»åçãè äžå šæ£è ã®
骚ç å€çã®çŸæ£ã®æ²»çãããã¯äºé²ã«æ¥µããŠæçš
ãªãã®ã§ããã ããããŠæ¬çºæã«ããã°ãäžèšåŒããã§è¡šã
ããã26âããã²ã³åãã¿ãã³D3èªå°äœãæå¹
æåãšããã«ã«ã·ãŠã 調ç¯å€ãæäŸãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã®æäžã¯çµ
å£ãéçµå£ã®ãããã§ããããéçµå£æäžã®å Žå
ã¯çèå ãç®äžãéèå ãçŽè žæäžçãããããª
ãã§ãçµå£æäžã奜ãŸãããæ¬ååç©ã掻æ§æå
ãšããã«ã«ã·ãŠã 調ç¯å€ã¯é å€ãæ£å€ãé¡ç²å€ã
åå€ãã«ãã»ã«å€ãã¢ã«ã³ãŒã«æº¶æ¶²å€ãæ²¹æ§æº¶æ¶²
å€ãæ°Žæ§æžæ¿å€ãªã©ã®æäžåœ¢æ ã§çšããããã é å€ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãäŸãã°ä¹³
ç³ããã³ãã³ãçé žã«ã«ã·ãŠã ãçµæ¶ã»ã«ããŒ
ã¹ãã±ã€é žãªã©ã®è³Šåœ¢å€ïŒã«ã«ããã·ã¡ãã«ã»ã«
ããŒã¹ãã¡ãã«ã»ã«ããŒã¹ããªã³é žã«ãªãŠã ãã
ãªããã«ãããªãã³ãªã©ã®çµåå€ïŒã¢ã«ã®ã³é žã
ããªãŠã ãçé žæ°ŽçŽ ãããªãŠã ãã©ãŠãªã«ç¡«é žã
ããªãŠã ãã¹ãã¢ãªã³é žã¢ãã°ãªã»ã©ã€ããªã©ã®
厩å£å€ïŒã°ãªã»ãªã³ãªã©ã®ä¿æ¹¿å€ïŒã«ãªãªã³ãã³
ãã€ãç¶ã±ã€é žãªã©ã®åžçå€ïŒç²Ÿè£œã¿ã«ã¯ãããŠ
é žæ«ãªã©ã®æ»æ²¢å€çãçšããŠéåžžã®æ¹æ³ã«ããæ
圢ããããšãã§ãããæ£å€ãé¡ç²å€ããåæ§ã«äž
èšã®è³Šåœ¢å€çãçšããŠéåžžã®æ¹æ³ã«ãã€ãŠæ圢ã
ãããšãã§ãããåå€ã®åœ¢æ ã«æ圢ããã«éããŠ
ã¯ãäŸãã°ããªãšãã¬ã³ã°ãªã³ãŒã«ãã«ã«ãªèã
é«çŽã¢ã«ã³ãŒã«ããŒã©ãã³ãªã©ãçšããŠåŸæ¥å ¬ç¥
ã®æ¹æ³ã«ããæ圢ããããšãã§ããã ã«ãã»ã«å€ã¯æ¬ååç©ã®æ²¹æ§æº¶æ¶²ãçšããŠè»ã«
ãã»ã«å€çã«ããããšã«ãã€ãŠåŸããããæ²¹æ§æº¶
液ã®æº¶åªãšããŠã¯æ€ç©æ²¹ãããšãã°ããŠã¢ãã³ã·
æ²¹ãæ£å®æ²¹ãã³ã³ãããæ²¹ãã¢ãŒã¢ã³ãæ²¹ãèœäž
çæ²¹ãéèæ²¹ãæ²¹ç¶ãšã¹ãã«ãªã©ã䜿çšããããš
ãã§ããã ã¢ã«ã³ãŒã«æº¶æ¶²å€ãæ²¹æ§æº¶æ¶²å€ãæ°Žæ§æžæ¿å€ãª
ã©ã¯å ¬ç¥ã®æ¹æ³ã«ãã€ãŠåŸãããšãã§ããã æ¬ååç©ã®ä¿å寿åœã延é·ããããã«ã補å€äž
ã«ãæé žåå€ãäŸãã°ã¢ã¹ã³ã«ãã³é žãããã«å
ããããã·ã¢ããœãŒã«ããããããã³ãªã©ãæ··å ¥
ããããšã§ãã§ããã æ¬çºæã®26âããã²ã³åãã¿ãã³D3èªå°äœã®
æäžéã¯ãæ£è ã®å¹Žéœ¢ãæ§å¥ãçŸæ£ã®çšåºŠãªã©ã«
ããé©å®éžæãããããéåžžïŒã200nïœïŒKgïŒ
æ¥ããã奜ãŸããã¯ïŒã40nïœïŒKgïŒæ¥ã§ããã
ãããæäžéãããåäœæäžåœ¢æ ã«ãã補å€ã«å«
æãããã26âããã²ã³åãã¿ãã³D3èªå°äœã®
éã決å®ãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã¯ããã骚
é«æ§çœè¡ç 现èã§ããHLâ60现èïŒããããã
ãšããµã€ãïŒã®é¡ç²çããã¯ããã¢ãŒãžãžã®åå
èªå°èœãæãããŸãå°è žã®cytosolç»åäžã®ãªã»
ãã¿ãŒèçœã«å¯Ÿããçµåèœãæããã26âããã²
ã³åãã¿ãã³D3èªå°äœã¯ã骚é«æ§çœè¡ç ã骚é«
å¢æ®çãçæ£å€è¡ççã«ãç¹ã«éªšé«æ§çœè¡ç ã«æ
å¹ã§ããã ãããã€ãŠæ¬çºæã«ããã°ãäžèšåŒããã§è¡š
ãããã26âããã²ã³åãã¿ãã³D3èªå°äœãæ
å¹æåãšããè±è «çå€ãæäŸãããã 26âããã²ã³åãã¿ãã³D3èªå°äœã®æäžã¯çµ
å£ã»éçµå£ã®ãããã§ããããéçµå£æäžã®å Žå
ã¯èŒžæ¶²çšæ³šå°å€ã泚å°å€çã®å€åã§éèå ãçè
å ãç®å ãããã¯è ¹è å æäžãããçµå£æäžã®å Ž
åã¯ãŒã©ãã³ãœããã«ãã»ã«å€ãé å€ãäžžå€ãé¡
ç²å€çã®å€åã§æäžãããããªãã§ãæ¬çºæã®è±
è «çå€ã«ãããŠã¯æŽ»æ§æåã§ãã26âããã²ã³å
ãã¿ãã³D3èªå°äœã®å«æéãã骚ç å€çã®æ²»ç
å€ã«äœ¿çšããå Žåã«æ¯ããŠãæ¯èŒçå€ãããå¿ èŠ
ã®ããããšãããå€åãšããŠã¯ãŒã©ãã³ãœããã«
ãã»ã«å€ã茞液çšæ³šå°å€ãç¹ã«å¥œãŸããã ãŒã©ãã³ãœããã«ãã»ã«å€ãšããŠã¯ããŒã©ã
ã³ãã°ãªã»ãªã³çã®é垞䜿çšãããçµæã§å€ç®ã
圢æãã26âããã²ã³åãã¿ãã³D3èªå°äœãè
èªé žã®ã°ãªã»ãªãé¡ãã³ã³ãããæ²¹ãã³ãŒã³ãªã€
ã«ããªãªãŒãæ²¹ããŽãæ²¹çã®æ²¹ç¶ã®èèªæ²¹ã«æº¶è§£
ããããŠããããå€ç®äžã«å å¡«ããããããšã«ã
ã€ãŠåŸããããã®ã奜ãŸãããæ¬çºæã®26âãã
ã²ã³åãã¿ãã³D3èªå°äœãè±è «çå€ãšããŠæäž
ãããšãã®æäžéã¯éåžžïŒã400nïœïŒKgïŒæ¥ã
ãã奜ãŸããã¯ïŒã100nïœïŒKgïŒæ¥ã§ãããã
ããã€ãŠïŒã«ãã»ã«äžã«å«æãããã26âããã²
ã³åãã¿ãã³D3èªå°äœã®éã¯ãè±è «çå€ãšããŠ
ã®å¹æãæäžã®åæ°çãèæ ®ããŠ0.1ã20ÎŒïœãç¹
ã«å¥œãŸããã¯0.25ã5ÎŒïœã§ããã 茞液çšæ³šå°å€ãšããŠã¯26âããã²ã³åãã¿ãã³
D3èªå°äœããªãªãŒãæ²¹ããŽãæ²¹ããã€ãºæ²¹ãã¡
ã³ãžãæ²¹çã®æ€ç©æ²¹ã§ããé氎溶æ§å€ããããã¯
ççé£å¡©æ¶²ããªã³ã²ã«æ¶²ã泚å°çšèžçæ°Žçã®æ°Žæ§
溶å€ã«é©åœãªæº¶è§£è£å©å€ãšãšãã«æº¶è§£ããããã
殺èããŠèŒžæ¶²çšæ³šå°å€ã«éåžžçšããããŠããã¬ã©
ã¹å®¹åšããã©ã¹ããã¯å®¹åšçã«å å¡«ããããããš
ã«ãã€ãŠåŸãããšãã§ããããã®ãããªèŒžæ¶²çšæ³š
å°å€äžã«å«æãã26âããã²ã³åãã¿ãã³D3èª
å°äœã®éã¯0.1ã20ÎŒïœãç¹ã«å¥œãŸããã¯0.5ã10ÎŒ
ïœã§ããã 以äžã«æ¬çºæãå®æœäŸã«ããæŽã«è©³çŽ°ã«èª¬æã
ãã åèäŸ ïŒ 24âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒ
ïŒâãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â1αïŒ3β
âãžãªãŒã«ïŒïŒãïŒã®åæ 24âãªããœã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³â1αïŒ
3βâãžãªãŒã«6.0ïœãããã©ããããã©ã³âå¡©å
ã¡ãã¬ã³ïŒïŒïŒïŒïŒ200mlã«æº¶è§£ããïŒâããšã
ã«âïŒïŒïŒïŒïŒâããªã¢ãŸãªã³âïŒïŒïŒâãžãªã³
ã®ã¢ã»ãã³æº¶æ¶²ãåå¿æ¶²ã®èµ€è²ãæ¶ããªããªããŸ
ã§æ»ŽäžãããïŒæéæ¹æããåŸãæžå§äžæº¶åªãæ¿
çž®ããåŸãããç²çæç©ãã·ãªã«ã²ã«ã«ã©ã ïŒæº¶
åªïŒãã³ãŒã³âã¢ã»ãã³ç³»ïŒã«ä»ãããšã«ããã
24âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒ
âãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â1αïŒ3βâãž
ãªãŒã«7.7ïœãåŸãããã®ãã®ã®ç©æ§å€ã¯æ¬¡ã®é
ãã§ãã€ãã MSïŒïœïŒïœ ïŒïŒ
ãåŒã
åèäŸ ïŒ
1αïŒ3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24âãªã
ãœâ5αïŒ8αâããšãã«âïŒïŒïŒâãŠã©ãŸãïŒ
ã³ã¬ã¹ãâïŒâãšã³ïŒïŒãïŒã®åæ 24âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒ
ïŒâãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â1αïŒ3βâ
ãžãªãŒã«7.5ïœã也ç¥å¡©åã¡ãã¬ã³50mlã«æžæ¿ã
ããïŒïŒ®âãžã€ãœãããã«ãšãã«ã¢ãã³6.7ïœ
ãå ãããïŒâã«å·åŽãçªçŽ æ°æµäžã¯ãã«ã¡ãã«
ã¡ãã«ãšãŒãã«4.15ïœããã€ãããšæ»ŽäžãããïŒ
æéåŸå®€æž©ã«æ»ããTLCã§åæãæ¶å€±ãããŸã§
åå¿ãç¶ãããåå¿çµäºåŸã1Nå¡©é žãå ãé ¢é ž
ãšãã«ããæœåºãããçé žæ°ŽçŽ ãããªãŠã 氎溶
液ã飜åé£å¡©æ°Žã§é 次æŽæµåŸãç¡æ°Žç¡«é žãããªãŠ
ã ã§ä¹Ÿç¥ãããæžå§äžæº¶åªãæ¿çž®ããåŸãããç²
çæç©ãã·ãªã«ã²ã«ã«ã©ã ïŒæº¶åªïŒãã³ãŒã³âã¢
ã»ãã³ç³»ïŒã§ç²Ÿè£œãã1αïŒ3βâãžïŒã¡ããã·ã¡
ããã·ïŒâ24âãªããœâ5αïŒ8αâïŒïŒâããšã
ã«âïŒïŒïŒâãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³ã
5.8ïœåŸãããã®ãã®ã®ç©æ§å€ã¯æ¬¡ã®éãã§ãã€
ãã NMRïŒCDCl3ïŒÎŽïŒppmïŒ 0.85ïŒ3HïŒïœïŒïŒ1.00ïŒ3HïŒïœïŒïŒ 1.09ïŒ6HïŒïœïŒïŒªïŒ7.2HzïŒïŒ 3.37ïŒ6HïŒïœïŒïŒ4.3ã5.0ïŒ4HïŒïœïŒïŒ 6.35ïŒ2HïŒABqïŒïŒ7.37ïŒ5HïŒïœïŒ MSïŒïœïŒïœ ïŒïŒ
ãœâ5αïŒ8αâããšãã«âïŒïŒïŒâãŠã©ãŸãïŒ
ã³ã¬ã¹ãâïŒâãšã³ïŒïŒãïŒã®åæ 24âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒ
ïŒâãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â1αïŒ3βâ
ãžãªãŒã«7.5ïœã也ç¥å¡©åã¡ãã¬ã³50mlã«æžæ¿ã
ããïŒïŒ®âãžã€ãœãããã«ãšãã«ã¢ãã³6.7ïœ
ãå ãããïŒâã«å·åŽãçªçŽ æ°æµäžã¯ãã«ã¡ãã«
ã¡ãã«ãšãŒãã«4.15ïœããã€ãããšæ»ŽäžãããïŒ
æéåŸå®€æž©ã«æ»ããTLCã§åæãæ¶å€±ãããŸã§
åå¿ãç¶ãããåå¿çµäºåŸã1Nå¡©é žãå ãé ¢é ž
ãšãã«ããæœåºãããçé žæ°ŽçŽ ãããªãŠã 氎溶
液ã飜åé£å¡©æ°Žã§é 次æŽæµåŸãç¡æ°Žç¡«é žãããªãŠ
ã ã§ä¹Ÿç¥ãããæžå§äžæº¶åªãæ¿çž®ããåŸãããç²
çæç©ãã·ãªã«ã²ã«ã«ã©ã ïŒæº¶åªïŒãã³ãŒã³âã¢
ã»ãã³ç³»ïŒã§ç²Ÿè£œãã1αïŒ3βâãžïŒã¡ããã·ã¡
ããã·ïŒâ24âãªããœâ5αïŒ8αâïŒïŒâããšã
ã«âïŒïŒïŒâãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³ã
5.8ïœåŸãããã®ãã®ã®ç©æ§å€ã¯æ¬¡ã®éãã§ãã€
ãã NMRïŒCDCl3ïŒÎŽïŒppmïŒ 0.85ïŒ3HïŒïœïŒïŒ1.00ïŒ3HïŒïœïŒïŒ 1.09ïŒ6HïŒïœïŒïŒªïŒ7.2HzïŒïŒ 3.37ïŒ6HïŒïœïŒïŒ4.3ã5.0ïŒ4HïŒïœïŒïŒ 6.35ïŒ2HïŒABqïŒïŒ7.37ïŒ5HïŒïœïŒ MSïŒïœïŒïœ ïŒïŒ
ãåŒã
åèäŸ ïŒ
1αïŒ3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24âãªã
ãœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©
ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â25âãªãŒã«ïŒïŒãïŒ
ã®åæ 1αïŒ3βâïŒã¡ããã·ã¡ããã·ïŒâ24âãªããœ
â5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©ãŸãïŒ
ã³ã¬ã¹ãâïŒâãšã³3.0ïœããžã°ã©ã€ã âïœâã
ã¿ããŒã«ïŒïŒïŒïŒïŒ90mlã«æº¶è§£ããïœâãããã·
ã«ãª4.95ïœãå ããŠãé žçŽ é°å²æ°äžâ20âã§é žçŽ
ã®åžåãæ¢ããŸã§æ¹æããã1.16ïœã®ããªããšã
ã«ãã¹ãã€ã³ãå ããã°ããæ¹æããåŸã1Nâ
å¡©é žãé ¢é žãšãã«ãå ããŠå液ãããææ©å±€ã
1Nâå¡©é žãçé žæ°ŽçŽ ãããªãŠã 氎溶液ã飜åé£
å¡©æ°Žã§é 次æŽæµåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ã
ããæžå§äžæº¶åªãæ¿çž®ããŠåŸãããç²çæç©ãã·
ãªã«ã²ã«ã«ã©ã ïŒæº¶åªïŒãã³ãŒã³âã¢ã»ãã³ç³»ïŒ
ã§ç²Ÿè£œãã1.91ïœã®1αïŒ3βâãžïŒã¡ããã·ã¡ãã
ã·ïŒâ24âãªããœâ5αïŒ8αâïŒïŒâããšãã«â
ãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â25âãªãŒã«ãåŸ
ãããã®ãã®ã®ç©æ§å€ã¯ä»¥äžã®éãã§ãã€ãã NMRïŒCDCl3ïŒÎŽïŒppmïŒ 0.86ïŒ3HïŒïœïŒïŒ1.00ïŒ3HïŒïœïŒïŒ 1.35ïŒ6HïŒïœïŒïŒ3.37ïŒ6HïŒïœïŒïŒ 4.3ã5.0ïŒ4HïŒïœïŒïŒ6.37ïŒ2HïŒABqïŒïŒ 7.3ã7.9ïŒ5HïŒïœïŒ MSïŒïœïŒïœ ïŒïŒ
ãœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©
ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â25âãªãŒã«ïŒïŒãïŒ
ã®åæ 1αïŒ3βâïŒã¡ããã·ã¡ããã·ïŒâ24âãªããœ
â5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©ãŸãïŒ
ã³ã¬ã¹ãâïŒâãšã³3.0ïœããžã°ã©ã€ã âïœâã
ã¿ããŒã«ïŒïŒïŒïŒïŒ90mlã«æº¶è§£ããïœâãããã·
ã«ãª4.95ïœãå ããŠãé žçŽ é°å²æ°äžâ20âã§é žçŽ
ã®åžåãæ¢ããŸã§æ¹æããã1.16ïœã®ããªããšã
ã«ãã¹ãã€ã³ãå ããã°ããæ¹æããåŸã1Nâ
å¡©é žãé ¢é žãšãã«ãå ããŠå液ãããææ©å±€ã
1Nâå¡©é žãçé žæ°ŽçŽ ãããªãŠã 氎溶液ã飜åé£
å¡©æ°Žã§é 次æŽæµåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ã
ããæžå§äžæº¶åªãæ¿çž®ããŠåŸãããç²çæç©ãã·
ãªã«ã²ã«ã«ã©ã ïŒæº¶åªïŒãã³ãŒã³âã¢ã»ãã³ç³»ïŒ
ã§ç²Ÿè£œãã1.91ïœã®1αïŒ3βâãžïŒã¡ããã·ã¡ãã
ã·ïŒâ24âãªããœâ5αïŒ8αâïŒïŒâããšãã«â
ãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â25âãªãŒã«ãåŸ
ãããã®ãã®ã®ç©æ§å€ã¯ä»¥äžã®éãã§ãã€ãã NMRïŒCDCl3ïŒÎŽïŒppmïŒ 0.86ïŒ3HïŒïœïŒïŒ1.00ïŒ3HïŒïœïŒïŒ 1.35ïŒ6HïŒïœïŒïŒ3.37ïŒ6HïŒïœïŒïŒ 4.3ã5.0ïŒ4HïŒïœïŒïŒ6.37ïŒ2HïŒABqïŒïŒ 7.3ã7.9ïŒ5HïŒïœïŒ MSïŒïœïŒïœ ïŒïŒ
ãåŒã
åèäŸ ïŒ
1αïŒ3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24âãªã
ãœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©
ãŸãïŒã³ã¬ã¹ã¿âïŒïŒ25âãžãšã³ïŒïŒãïŒã®åæ 110mgã®1αïŒ3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24
âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâ
ãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â25âãªãŒã«ãã
ã³ãŒã³10mlã«æº¶è§£ããã¡ãã«ïŒã«ã«ããã·ã¹ã«ã
ã¢ã¢ã€ã«ïŒããªãšãã«ã¢ã³ã¢ããŠã ãã€ãããªã
ãµã€ã110mgãå ããçªçŽ é°å²æ°äžã§ïŒæéåå
ç±éæµããã æ°Žãå ããŠé ¢é žãšãã«ããæœåºãã飜åé£å¡©æ°Ž
ã§æŽæµãããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸãæžå§
äžæº¶åªãæ¿çž®ããã·ãªã«ã²ã«ã«ã©ã ïŒæº¶åªïŒãã³
ãŒã³âé ¢é žãšãã«ç³»ïŒã§ç²Ÿè£œããã34mgã®1αïŒ
3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24âãªããœâ5αïŒ
8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©ãŸãïŒã³ã¬
ã¹ã¿âïŒïŒ25âãžãšã³ãåŸãããã®ãã®ã®ç©æ§å€
ã¯ä»¥äžã®éãã§ãã€ãã NMRïŒCDCl3ïŒÎŽïŒppmïŒ 0.83ïŒ3HïŒïœïŒïŒ0.98ïŒ3HïŒïœïŒïŒ 1.87ïŒ3HïŒïœïŒ3.33ïŒ6HïŒïœïŒïŒ 4.35ã5.0ïŒ4HïŒïœïŒïŒ5.73ïŒ1HïŒbrïŒïœïŒïŒ 5.93ïŒ1HïŒbrïŒïœïŒïŒ6.35ïŒ2HïŒABqïŒïŒ 7.3ã7.9ïŒ5HïŒïœïŒ MSïŒïœïŒïœ ïŒïŒ
ãœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©
ãŸãïŒã³ã¬ã¹ã¿âïŒïŒ25âãžãšã³ïŒïŒãïŒã®åæ 110mgã®1αïŒ3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24
âãªããœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâ
ãŠã©ãŸãïŒã³ã¬ã¹ãâïŒâãšã³â25âãªãŒã«ãã
ã³ãŒã³10mlã«æº¶è§£ããã¡ãã«ïŒã«ã«ããã·ã¹ã«ã
ã¢ã¢ã€ã«ïŒããªãšãã«ã¢ã³ã¢ããŠã ãã€ãããªã
ãµã€ã110mgãå ããçªçŽ é°å²æ°äžã§ïŒæéåå
ç±éæµããã æ°Žãå ããŠé ¢é žãšãã«ããæœåºãã飜åé£å¡©æ°Ž
ã§æŽæµãããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸãæžå§
äžæº¶åªãæ¿çž®ããã·ãªã«ã²ã«ã«ã©ã ïŒæº¶åªïŒãã³
ãŒã³âé ¢é žãšãã«ç³»ïŒã§ç²Ÿè£œããã34mgã®1αïŒ
3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24âãªããœâ5αïŒ
8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©ãŸãïŒã³ã¬
ã¹ã¿âïŒïŒ25âãžãšã³ãåŸãããã®ãã®ã®ç©æ§å€
ã¯ä»¥äžã®éãã§ãã€ãã NMRïŒCDCl3ïŒÎŽïŒppmïŒ 0.83ïŒ3HïŒïœïŒïŒ0.98ïŒ3HïŒïœïŒïŒ 1.87ïŒ3HïŒïœïŒ3.33ïŒ6HïŒïœïŒïŒ 4.35ã5.0ïŒ4HïŒïœïŒïŒ5.73ïŒ1HïŒbrïŒïœïŒïŒ 5.93ïŒ1HïŒbrïŒïœïŒïŒ6.35ïŒ2HïŒABqïŒïŒ 7.3ã7.9ïŒ5HïŒïœïŒ MSïŒïœïŒïœ ïŒïŒ
ãåŒã
åèäŸ ïŒ
24âãªããœâ26âã¯ãã«â1αïŒ3βâãžããã
ãã·ã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³ïŒïŒïŒã®åæ 1αïŒ3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24âãªã
ãœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©ãŸ
ãïŒã³ã¬ã¹ã¿âïŒïŒ25âãžãšã³180mgãããã©ã
ãããã©ã³âã¡ã¿ããŒã«ïŒïŒïŒïŒïŒ18mlã«æº¶è§£
ããïŒâã§å¡©é žã¬ã¹ãïŒåéããã«ãããæŽã«æ¿
å¡©é žã觊åªéå ããŠã50âã§15æéå ç±æ¹æã
ããæžå§äžæº¶åªãé€å»ããåŸãããæ®æž£ãïœâã³
ãªãžã³18mlã«æº¶è§£ãã15åéå ç±éæµãããåå¿
çµäºåŸ6Nâå¡©é žãå ãé ¢é žãšãã«ããæœåºããã
1Nâå¡©é žãçé žæ°ŽçŽ ãããªãŠã 氎溶液ã飜åé£
å¡©æ°Žã§é 次æŽæµåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ã
ããæžå§äžæº¶åªãæ¿çž®ããåŸãããç²çæç©ãã·
ãªã«ã²ã«èå±€ã¯ãããã°ã©ãã€ãŒã§ïŒå粟補ïŒæº¶
åªç³»ïŒãã³ãŒã³âã¢ã»ãã³ç³»åã³ïœâãããµã³â
ïŒâãããããŒã«ç³»ïŒããããšã«ãããïŒmgã®24
âãªããœâ26âã¯ãã«â1αïŒ3βâãžããããã·
ã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³ãåŸãããã®ãã®ã®ç©
æ§å€ã¯æ¬¡ã®éãã§ãã€ãã UVïŒÎ»EtOH nax,onïŒïŒ294ïŒ282ïŒ271ïŒ262ïŒshïŒ MSïŒïœïŒïœ ïŒïŒ448ïŒM+ïŒïŒ450ïŒM+ïŒïŒïŒ å®æœäŸ ïŒ (i) 24âãªããœâ26âã¯ãã«â1αïŒ3βâãžãã
ããã·ã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³ïŒmgãè±é žçŽ
åãã600mlã®ãã³ãŒã³âãšã¿ããŒã«ïŒïŒïŒïŒïŒ
ã«æº¶è§£ãããåŸããã溶液ãïŒâã«ã³ã³ãããŒ
ã«ããªããæ¹æäžïŒåéããã€ã³ãŒã«ãã€ã«ã¿
ãŒã«ããå²ãŸãã200Wã®ãããã¢ã©ã³ãã䜿
ã€ãŠç §å°ããã次ã«ãã®æº¶æ¶²ãïŒæéåå ç±é
æµãããåå¿çµäºåŸãåå¿æ¶²ã30â以äžã§æžå§
äžæ¿çž®ãããåŸãããç²çæç©ãã·ãªã«ã²ã«è
å±€ã¯ãããã°ã©ãã€ãŒã§ïŒå粟補ïŒæº¶åªç³»ïŒã
ã³ãŒã³âã¢ã»ãã³ç³»åã³ïœâãããµã³âïŒâã
ããããŒã«ç³»ïŒããã次ãã§åŸããã粟補ç©ã
ZorbaxâSilã«ã©ã ãçšããé«é液äœã¯ããã
ã°ã©ãã€ãŒã§ã溶åºæ¶²ãšããŠ1.6ïŒ ã¡ã¿ããŒ
ã«ïŒãžã¯ãã«ã¡ã¿ã³ãçšããŠæŽã«ç²Ÿè£œãä¿ææ
é15.7åã§æº¶åºãããç»åãååããŠ24âãªã
ãœâ26âã¯ãã«â1αâããããã·ãã¿ãã³D3
ãåŸãããã®ãã®ã®ç©æ§å€ã¯æ¬¡ã®éãã§ãã€
ãã UVïŒEtOHïŒnmïŒïŒÎ»max264 λmin227 FDâMSïŒïœïŒïœ ïŒïŒ448ïŒM+ïŒïŒ450ïŒM+ïŒïŒïŒ NMRïŒCDCl3ïŒÎŽïŒppmïŒïŒ 0.54ïŒ3HïŒïœïŒïŒ0.92ïŒ3HïŒïœïŒïŒªïŒ6.4HzïŒïŒ 1.19ïŒ3HïŒïœïŒïŒªïŒ7.17HzïŒïŒ 3.47ã3.52ïŒ2HïŒïœïŒïŒ4.23ïŒ1HïŒïœïŒïŒ 4.44ïŒ1HïŒïœïŒïŒ5.00ïŒ1HïŒïœïŒïŒ 5.33ïŒ1HïŒïœïŒïŒ6.01ïŒ1HïŒïœïŒïŒªïŒ11.3HzïŒïŒ 6.38ïŒ1HïŒïœïŒïŒªïŒ11.3HzïŒ (ii) 24âãªããœâ26âã¯ãã«â1αâããããã·
ãã¿ãã³D370ÎŒïœãïŒmlã®ãšã¿ããŒã«ã«æº¶è§£
ããããã«ïŒmgã®NaBH4ãå ããŠæ¹æããªã
ã宀枩ã§ïŒæéåå¿ãããåå¿åŸïŒmlã®é ¢é žãš
ãã«ãå ããæŽã«ïŒmlã®æ°Žãå ãããé ¢é žãšã
ã«æœåºãïŒåè¡ãªãåå¿çæç©ãæœåºãããå
å¿çæç©ã¯ZorbaxâSilã«ã©ã ïŒ4.6Ã250mmïŒ
ãçšããé«é液äœã¯ãããã°ã©ãã€ãŒ
ïŒHPLCïŒã§æº¶åºæ¶²ãšããŠ2.0ïŒ ã¡ã¿ããŒã«âãž
ã¯ãã«ã¡ã¿ã³ã§è¡ãªã€ãããã®HPLCã«ãã€ãŠ
26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ãš26âã¯ãã«â1αïŒ24ïŒïŒ³ïŒâãžããã
ãã·ãã¿ãã³D3ãããããçŽ25ÎŒïœãã€åé¢ç²Ÿ
補ããã äž¡è ã®ãšã¿ããŒã«æº¶æ¶²ã®UVã¹ãã¯ãã«ã¯
264nmã«æ¥µå€§åžåã227nmã«æ¥µå°åžåãæããŠ
ããã å®æœäŸ ïŒ è žç®¡ããã®ã«ã«ã·ãŠã åžå掻æ§åã³éªšå¡©æº¶è§£æŽ»
æ§ é¢ä¹³çŽåŸã®male Wistar ratãïŒé±éãã¿ãã³
ïŒ€æ¬ ä¹äœã«ã«ã·ãŠã 飌æïŒCaïŒ0.0036ïŒ ïŒïŒ°ïŒ
0.3ïŒ ïŒã§é£Œè²ããããã®ã©ããã«250nïœã®26â
ã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿ãã³D3
ãããã¯26âã¯ãã«â1αïŒ24ïŒïŒ³ïŒâãžãããã
ã·ãã¿ãã³D3ãããã¯24âãªããœâ26âã¯ãã«
â1αâããããã·ãã¿ãã³D3ã0.2ïŒ Triton 
â100溶液0.2mlã«æº¶è§£ãéèå æäžãåæéåŸã®
å°è žããã®ã«ã«ã·ãŠã åžåãè žç®¡å転æ³
ãMartinïŒD.L.and DeLuCaïŒH.F.ïŒAm.J.
Physiol.216ïŒ1351â1359ïŒ1969ïŒãã§æž¬å®ããè¡
æž äžã«ã«ã·ãŠã éã®äžæãã骚塩溶解掻æ§ã枬å®
ãããè¡æž äžã«ã«ã·ãŠã éã¯OCPCæ³
ïŒConnertyïŒH.V.and BriggsïŒA.R.ïŒAm.J.
Clin.Pathol.45ïŒ290â296ïŒ1966ïŒïŒã§æž¬å®ããã
çµæã¯ç¬¬ïŒå³åã³ç¬¬ïŒå³ã«ç€ºãããšããã§ããã 第ïŒå³ã第ïŒå³ããæãããªããã«æ¬çºæã®å
åç©ã¯ããããã«ã«ã·ãŠã åžå掻æ§ã骚塩溶解掻
æ§ãæãããŸããããã®äœçšæç¶æéãé·ããã®
ã§ããã å®æœäŸïŒ ãªã»ãã¿ãŒãšã®çµå芪åæ§ ãªã»ãã¿ãŒãš24âãªããœâ26âã¯ãã«â1αâ
ããããã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ24
ïŒïŒ²ïŒâãžããããã·ãã¿ãã³D3åã³26âã¯ãã«
â1αïŒ24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ãšã®çµ
å芪åæ§ã¯ãEismanãã®æ¹æ³ãEismanïŒJ.A.ïŒ
HamstraïŒA.J.ïŒKreamïŒB.E.and DeLucaïŒ
H.F.ïŒArch.Biochem.Biophys.176ïŒ235â243
ïŒ1976ïŒãã®å€æ³ãIshizukaïŒS.ïŒBannai.K.ïŒ
NaruchiïŒT.and HashimotoïŒY.SteroidsïŒ37ïŒ
33â43ïŒ1981ïŒãã«åŸã€ãŠè¡ãªã€ããå³ã¡ããªã»ã
ã¿ãŒãå«ããµã€ããŸãŒã«ç»åïŒ0.3mgproteinïŒ
mlïŒïŒmlã«10000dpmã®ã3Hã1αïŒ25â
ïŒOHïŒ2D3ïŒS.A163CiïŒmmolïŒãå ããæŽã«çš®ã
ã®æ¿åºŠã®24âãªããœâ26âã¯ãã«â1αâããã
ãã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãž
ããããã·ãã¿ãã³D3ãããã¯26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ãå ããŠ25â
ã§60åéã€ã³ããŠããŒããããåå¿åŸ40ïŒ ïŒïŒ·ïŒ
ïŒã®ããªãšãã¬ã³ã°ãªã³ãŒã«6000ãïŒmlå ããŠ
ããæ¹æã2260Ãïœ60åéé å¿åé¢ããŠåŸãæ²æŸ±
éšåã®æŸå°èœã枬å®ããŠãªã»ãã¿ãŒã«çµåãã
ã3Hãâ1αïŒ25âïŒOHïŒ2D3éã枬å®ããããã®
枬å®å€ããã1αïŒ25âïŒOHïŒ2D3ã®ãªã»ãã¿ãŒã«
察ãã芪åæ§ãïŒãšãããšãã®ã24âãªããœâ26
âã¯ãã«â1αâããããã·ãã¿ãã³D3ã®èŠªåæ§
ã¯1.38ïŒ26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžãããã
ã·ãã¿ãã³D3ã®èŠªåæ§ã¯0.72ïŒ26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ã®èŠªåæ§ã¯
11.45ã§ãã€ãã å®æœäŸïŒ ååèªå°èœã®æž¬å® 现èã¯ããããããšããµã€ãHLâ60å¹é€çŽ°è
ç³»ãçšããã现èã¯RPMI1640ïŒ15ïŒ FCSå¹å°äž
37âïŒïŒïŒ CO295ïŒ ç©ºæ°ã®ç°å¢ã§å¹é€ããã被éš
ååç©ã¯10ÎŒïœïŒmlãäžéãšããå¹å°äžã¢ã«ã³ãŒ
ã«æ¿åºŠã¯ïŒïŒ 以äžãšãããååèªå°èœã¯ã¹ãŒããŒ
ãªãã·ãçæãææšãšããŠæž¬å®ããã ã¹ãŒããŒãªãã·ãçæã¯ãïŒãïŒÃ105现èïŒ
mlã§è¢«éšååç©ååšäžã§48æéå¹é€åŸããªã³é žã
ããã¢ãŒïŒPBSïŒã§æŽããç¡è¡æž å¹å°ãå ãã
ãããã«âããã©ãŸãªãŠã ïŒNBTïŒåã³ããã©
ãã«ãã€ã«ãã«ããŒã«â13âã¢ã»ããŒãïŒTPAïŒ
ãæ·»å ãã37âã20åéã€ã³ããŠããŒãã现èã®
çè²ã§æž¬å®ãããçè²çŽ°èæ°åã³å šçŽ°èæ°ãé¡åŸ®
é¡äžã§èšæ°ããNBTéœæ§çŸåçãæ±ãããå®é
çãªæŽ»æ§æ¯èŒã¯ãéœæ§çã察æ°æ¿åºŠã«å¯ŸããŠãã
ãããæ²ç·ãç»ããå³äžã§ED50ïŒçŽ°èã®50ïŒ ã
NBTéœæ§ãšãªãæ¿åºŠïŒãæ±ããŠè¡ãªã€ãã çµæã¯ç¬¬ïŒè¡šã«ç€ºããéãã§ããã
ãã·ã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³ïŒïŒïŒã®åæ 1αïŒ3βâãžïŒã¡ããã·ã¡ããã·ïŒâ24âãªã
ãœâ5αïŒ8αâïŒïŒâããšãã«âïŒïŒïŒâãŠã©ãŸ
ãïŒã³ã¬ã¹ã¿âïŒïŒ25âãžãšã³180mgãããã©ã
ãããã©ã³âã¡ã¿ããŒã«ïŒïŒïŒïŒïŒ18mlã«æº¶è§£
ããïŒâã§å¡©é žã¬ã¹ãïŒåéããã«ãããæŽã«æ¿
å¡©é žã觊åªéå ããŠã50âã§15æéå ç±æ¹æã
ããæžå§äžæº¶åªãé€å»ããåŸãããæ®æž£ãïœâã³
ãªãžã³18mlã«æº¶è§£ãã15åéå ç±éæµãããåå¿
çµäºåŸ6Nâå¡©é žãå ãé ¢é žãšãã«ããæœåºããã
1Nâå¡©é žãçé žæ°ŽçŽ ãããªãŠã 氎溶液ã飜åé£
å¡©æ°Žã§é 次æŽæµåŸãç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥ã
ããæžå§äžæº¶åªãæ¿çž®ããåŸãããç²çæç©ãã·
ãªã«ã²ã«èå±€ã¯ãããã°ã©ãã€ãŒã§ïŒå粟補ïŒæº¶
åªç³»ïŒãã³ãŒã³âã¢ã»ãã³ç³»åã³ïœâãããµã³â
ïŒâãããããŒã«ç³»ïŒããããšã«ãããïŒmgã®24
âãªããœâ26âã¯ãã«â1αïŒ3βâãžããããã·
ã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³ãåŸãããã®ãã®ã®ç©
æ§å€ã¯æ¬¡ã®éãã§ãã€ãã UVïŒÎ»EtOH nax,onïŒïŒ294ïŒ282ïŒ271ïŒ262ïŒshïŒ MSïŒïœïŒïœ ïŒïŒ448ïŒM+ïŒïŒ450ïŒM+ïŒïŒïŒ å®æœäŸ ïŒ (i) 24âãªããœâ26âã¯ãã«â1αïŒ3βâãžãã
ããã·ã³ã¬ã¹ã¿âïŒïŒïŒâãžãšã³ïŒmgãè±é žçŽ
åãã600mlã®ãã³ãŒã³âãšã¿ããŒã«ïŒïŒïŒïŒïŒ
ã«æº¶è§£ãããåŸããã溶液ãïŒâã«ã³ã³ãããŒ
ã«ããªããæ¹æäžïŒåéããã€ã³ãŒã«ãã€ã«ã¿
ãŒã«ããå²ãŸãã200Wã®ãããã¢ã©ã³ãã䜿
ã€ãŠç §å°ããã次ã«ãã®æº¶æ¶²ãïŒæéåå ç±é
æµãããåå¿çµäºåŸãåå¿æ¶²ã30â以äžã§æžå§
äžæ¿çž®ãããåŸãããç²çæç©ãã·ãªã«ã²ã«è
å±€ã¯ãããã°ã©ãã€ãŒã§ïŒå粟補ïŒæº¶åªç³»ïŒã
ã³ãŒã³âã¢ã»ãã³ç³»åã³ïœâãããµã³âïŒâã
ããããŒã«ç³»ïŒããã次ãã§åŸããã粟補ç©ã
ZorbaxâSilã«ã©ã ãçšããé«é液äœã¯ããã
ã°ã©ãã€ãŒã§ã溶åºæ¶²ãšããŠ1.6ïŒ ã¡ã¿ããŒ
ã«ïŒãžã¯ãã«ã¡ã¿ã³ãçšããŠæŽã«ç²Ÿè£œãä¿ææ
é15.7åã§æº¶åºãããç»åãååããŠ24âãªã
ãœâ26âã¯ãã«â1αâããããã·ãã¿ãã³D3
ãåŸãããã®ãã®ã®ç©æ§å€ã¯æ¬¡ã®éãã§ãã€
ãã UVïŒEtOHïŒnmïŒïŒÎ»max264 λmin227 FDâMSïŒïœïŒïœ ïŒïŒ448ïŒM+ïŒïŒ450ïŒM+ïŒïŒïŒ NMRïŒCDCl3ïŒÎŽïŒppmïŒïŒ 0.54ïŒ3HïŒïœïŒïŒ0.92ïŒ3HïŒïœïŒïŒªïŒ6.4HzïŒïŒ 1.19ïŒ3HïŒïœïŒïŒªïŒ7.17HzïŒïŒ 3.47ã3.52ïŒ2HïŒïœïŒïŒ4.23ïŒ1HïŒïœïŒïŒ 4.44ïŒ1HïŒïœïŒïŒ5.00ïŒ1HïŒïœïŒïŒ 5.33ïŒ1HïŒïœïŒïŒ6.01ïŒ1HïŒïœïŒïŒªïŒ11.3HzïŒïŒ 6.38ïŒ1HïŒïœïŒïŒªïŒ11.3HzïŒ (ii) 24âãªããœâ26âã¯ãã«â1αâããããã·
ãã¿ãã³D370ÎŒïœãïŒmlã®ãšã¿ããŒã«ã«æº¶è§£
ããããã«ïŒmgã®NaBH4ãå ããŠæ¹æããªã
ã宀枩ã§ïŒæéåå¿ãããåå¿åŸïŒmlã®é ¢é žãš
ãã«ãå ããæŽã«ïŒmlã®æ°Žãå ãããé ¢é žãšã
ã«æœåºãïŒåè¡ãªãåå¿çæç©ãæœåºãããå
å¿çæç©ã¯ZorbaxâSilã«ã©ã ïŒ4.6Ã250mmïŒ
ãçšããé«é液äœã¯ãããã°ã©ãã€ãŒ
ïŒHPLCïŒã§æº¶åºæ¶²ãšããŠ2.0ïŒ ã¡ã¿ããŒã«âãž
ã¯ãã«ã¡ã¿ã³ã§è¡ãªã€ãããã®HPLCã«ãã€ãŠ
26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿
ãã³D3ãš26âã¯ãã«â1αïŒ24ïŒïŒ³ïŒâãžããã
ãã·ãã¿ãã³D3ãããããçŽ25ÎŒïœãã€åé¢ç²Ÿ
補ããã äž¡è ã®ãšã¿ããŒã«æº¶æ¶²ã®UVã¹ãã¯ãã«ã¯
264nmã«æ¥µå€§åžåã227nmã«æ¥µå°åžåãæããŠ
ããã å®æœäŸ ïŒ è žç®¡ããã®ã«ã«ã·ãŠã åžå掻æ§åã³éªšå¡©æº¶è§£æŽ»
æ§ é¢ä¹³çŽåŸã®male Wistar ratãïŒé±éãã¿ãã³
ïŒ€æ¬ ä¹äœã«ã«ã·ãŠã 飌æïŒCaïŒ0.0036ïŒ ïŒïŒ°ïŒ
0.3ïŒ ïŒã§é£Œè²ããããã®ã©ããã«250nïœã®26â
ã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžããããã·ãã¿ãã³D3
ãããã¯26âã¯ãã«â1αïŒ24ïŒïŒ³ïŒâãžãããã
ã·ãã¿ãã³D3ãããã¯24âãªããœâ26âã¯ãã«
â1αâããããã·ãã¿ãã³D3ã0.2ïŒ Triton 
â100溶液0.2mlã«æº¶è§£ãéèå æäžãåæéåŸã®
å°è žããã®ã«ã«ã·ãŠã åžåãè žç®¡å転æ³
ãMartinïŒD.L.and DeLuCaïŒH.F.ïŒAm.J.
Physiol.216ïŒ1351â1359ïŒ1969ïŒãã§æž¬å®ããè¡
æž äžã«ã«ã·ãŠã éã®äžæãã骚塩溶解掻æ§ã枬å®
ãããè¡æž äžã«ã«ã·ãŠã éã¯OCPCæ³
ïŒConnertyïŒH.V.and BriggsïŒA.R.ïŒAm.J.
Clin.Pathol.45ïŒ290â296ïŒ1966ïŒïŒã§æž¬å®ããã
çµæã¯ç¬¬ïŒå³åã³ç¬¬ïŒå³ã«ç€ºãããšããã§ããã 第ïŒå³ã第ïŒå³ããæãããªããã«æ¬çºæã®å
åç©ã¯ããããã«ã«ã·ãŠã åžå掻æ§ã骚塩溶解掻
æ§ãæãããŸããããã®äœçšæç¶æéãé·ããã®
ã§ããã å®æœäŸïŒ ãªã»ãã¿ãŒãšã®çµå芪åæ§ ãªã»ãã¿ãŒãš24âãªããœâ26âã¯ãã«â1αâ
ããããã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ24
ïŒïŒ²ïŒâãžããããã·ãã¿ãã³D3åã³26âã¯ãã«
â1αïŒ24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ãšã®çµ
å芪åæ§ã¯ãEismanãã®æ¹æ³ãEismanïŒJ.A.ïŒ
HamstraïŒA.J.ïŒKreamïŒB.E.and DeLucaïŒ
H.F.ïŒArch.Biochem.Biophys.176ïŒ235â243
ïŒ1976ïŒãã®å€æ³ãIshizukaïŒS.ïŒBannai.K.ïŒ
NaruchiïŒT.and HashimotoïŒY.SteroidsïŒ37ïŒ
33â43ïŒ1981ïŒãã«åŸã€ãŠè¡ãªã€ããå³ã¡ããªã»ã
ã¿ãŒãå«ããµã€ããŸãŒã«ç»åïŒ0.3mgproteinïŒ
mlïŒïŒmlã«10000dpmã®ã3Hã1αïŒ25â
ïŒOHïŒ2D3ïŒS.A163CiïŒmmolïŒãå ããæŽã«çš®ã
ã®æ¿åºŠã®24âãªããœâ26âã¯ãã«â1αâããã
ãã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãž
ããããã·ãã¿ãã³D3ãããã¯26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ãå ããŠ25â
ã§60åéã€ã³ããŠããŒããããåå¿åŸ40ïŒ ïŒïŒ·ïŒ
ïŒã®ããªãšãã¬ã³ã°ãªã³ãŒã«6000ãïŒmlå ããŠ
ããæ¹æã2260Ãïœ60åéé å¿åé¢ããŠåŸãæ²æŸ±
éšåã®æŸå°èœã枬å®ããŠãªã»ãã¿ãŒã«çµåãã
ã3Hãâ1αïŒ25âïŒOHïŒ2D3éã枬å®ããããã®
枬å®å€ããã1αïŒ25âïŒOHïŒ2D3ã®ãªã»ãã¿ãŒã«
察ãã芪åæ§ãïŒãšãããšãã®ã24âãªããœâ26
âã¯ãã«â1αâããããã·ãã¿ãã³D3ã®èŠªåæ§
ã¯1.38ïŒ26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâãžãããã
ã·ãã¿ãã³D3ã®èŠªåæ§ã¯0.72ïŒ26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ã®èŠªåæ§ã¯
11.45ã§ãã€ãã å®æœäŸïŒ ååèªå°èœã®æž¬å® 现èã¯ããããããšããµã€ãHLâ60å¹é€çŽ°è
ç³»ãçšããã现èã¯RPMI1640ïŒ15ïŒ FCSå¹å°äž
37âïŒïŒïŒ CO295ïŒ ç©ºæ°ã®ç°å¢ã§å¹é€ããã被éš
ååç©ã¯10ÎŒïœïŒmlãäžéãšããå¹å°äžã¢ã«ã³ãŒ
ã«æ¿åºŠã¯ïŒïŒ 以äžãšãããååèªå°èœã¯ã¹ãŒããŒ
ãªãã·ãçæãææšãšããŠæž¬å®ããã ã¹ãŒããŒãªãã·ãçæã¯ãïŒãïŒÃ105现èïŒ
mlã§è¢«éšååç©ååšäžã§48æéå¹é€åŸããªã³é žã
ããã¢ãŒïŒPBSïŒã§æŽããç¡è¡æž å¹å°ãå ãã
ãããã«âããã©ãŸãªãŠã ïŒNBTïŒåã³ããã©
ãã«ãã€ã«ãã«ããŒã«â13âã¢ã»ããŒãïŒTPAïŒ
ãæ·»å ãã37âã20åéã€ã³ããŠããŒãã现èã®
çè²ã§æž¬å®ãããçè²çŽ°èæ°åã³å šçŽ°èæ°ãé¡åŸ®
é¡äžã§èšæ°ããNBTéœæ§çŸåçãæ±ãããå®é
çãªæŽ»æ§æ¯èŒã¯ãéœæ§çã察æ°æ¿åºŠã«å¯ŸããŠãã
ãããæ²ç·ãç»ããå³äžã§ED50ïŒçŽ°èã®50ïŒ ã
NBTéœæ§ãšãªãæ¿åºŠïŒãæ±ããŠè¡ãªã€ãã çµæã¯ç¬¬ïŒè¡šã«ç€ºããéãã§ããã
ãè¡šã
å®æœäŸ ïŒ
24âãªããœâ26âã¯ãã«â1αâããããã·ã
ã¿ãã³D3ãã³ã³ãããæ²¹ã«æº¶è§£ããŠ7ÎŒïœïŒmlã®
æ¿åºŠã®æ²¹æ§æº¶æ¶²ãåŸãã ãŒã©ãã³ãã°ãªã»ãªã³ããã©ãªãã·å®æ¯éŠé žãš
ãã«ã粟補氎ãå 枩溶解ããŠè¢«èŠå€ãšããäžèšæ²¹
æ§æº¶æ¶²ãçšããŠãïŒã«ãã»ã«ã«ã€ã24âãªããœâ
26âã¯ãã«â1αâããããã·ãã¿ãã³D3ã1ÎŒïœ
å«æããããã«é£ç¶åŒè»ã«ãã»ã«è£œé æ©ãçšããŠ
è»ã«ãã»ã«ã補é ããã åæ§ã®æ¹æ³ã«ããã26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒ
âãžããããã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ã«ã€ããŠãã
ããã1ÎŒïœå«æãããããªè»ã«ãã»ã«ã補é ã
ãã
ã¿ãã³D3ãã³ã³ãããæ²¹ã«æº¶è§£ããŠ7ÎŒïœïŒmlã®
æ¿åºŠã®æ²¹æ§æº¶æ¶²ãåŸãã ãŒã©ãã³ãã°ãªã»ãªã³ããã©ãªãã·å®æ¯éŠé žãš
ãã«ã粟補氎ãå 枩溶解ããŠè¢«èŠå€ãšããäžèšæ²¹
æ§æº¶æ¶²ãçšããŠãïŒã«ãã»ã«ã«ã€ã24âãªããœâ
26âã¯ãã«â1αâããããã·ãã¿ãã³D3ã1ÎŒïœ
å«æããããã«é£ç¶åŒè»ã«ãã»ã«è£œé æ©ãçšããŠ
è»ã«ãã»ã«ã補é ããã åæ§ã®æ¹æ³ã«ããã26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒ
âãžããããã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ã«ã€ããŠãã
ããã1ÎŒïœå«æãããããªè»ã«ãã»ã«ã補é ã
ãã
第ïŒå³ã¯24âãªããœâ26âã¯ãã«â1αâãã
ããã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâ
ãžããããã·ãã¿ãã³D3åã³26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ã®è žç®¡ããã®
ã«ã«ã·ãŠã åžå掻æ§ã瀺ãããã®ã§ããã第ïŒå³
ã¯éªšå¡©æº¶è§£æŽ»æ§ã瀺ãããã®ã§ããã
ããã·ãã¿ãã³D3ïŒ26âã¯ãã«â1αïŒ24ïŒïŒ²ïŒâ
ãžããããã·ãã¿ãã³D3åã³26âã¯ãã«â1αïŒ
24ïŒïŒ³ïŒâãžããããã·ãã¿ãã³D3ã®è žç®¡ããã®
ã«ã«ã·ãŠã åžå掻æ§ã瀺ãããã®ã§ããã第ïŒå³
ã¯éªšå¡©æº¶è§£æŽ»æ§ã瀺ãããã®ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžèšåŒãã ãåŒäžãã¯ããã²ã³ååãã¯ããããã·ã¡
ãã¬ã³åºåã¯ã«ã«ããã«åºãã¯æ°ŽçŽ åååã¯æ°Ž
é žåºãè¡šãããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœã ïŒ äžèšåŒãâïœã ãåŒäžãã¯ããã²ã³ååãRâ²ã¯æ°ŽçŽ ååã
æ°Žé žåºåã¯ä¿è·ãããæ°Žé žåºãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šãããã ã§è¡šãããã26âããã²ã³åã³ã¬ã¹ã¿ãŒïŒïŒïŒâ
ãžãšã³èªå°äœã玫å€ç·ç §å°ã次ãã§ç±ç°æ§ååå¿
ã«ä»ããå¿ èŠã«å¿ããŠè±ä¿è·ããããšãç¹åŸŽãšã
ãäžèšåŒãâïœã ãåŒäžãã¯ããã²ã³ååãã¯æ°ŽçŽ åååã¯
æ°Žé žåºãè¡šãããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœ
ã®è£œé æ³ã ïŒ äžèšåŒãâaâ²ã ãåŒäžãã¯ããã²ã³ååãRâ²ã¯æ°ŽçŽ ååã
æ°Žé žåºåã¯ä¿è·ãããæ°Žé žåºãRâ³ã¯æ°ŽçŽ ååå
ã¯ä¿è·åºãè¡šãããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœ
ãéå åå¿ã«ä»ãã次ãã§å¿ èŠã«å¿ããŠè±ä¿è·ã
ãããšãç¹åŸŽãšããäžèšåŒãâïœã ãåŒäžãã¯ããã²ã³ååãã¯æ°ŽçŽ åååã¯
æ°Žé žåºãè¡šãããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœ
ã®è£œé æ³ã ïŒ äžèšåŒãã ãåŒäžãïŒïŒžåã³ïŒ²ã¯äžèšå®çŸ©ã«åããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœ
ãæå¹æåãšããã«ã«ã·ãŠã 調ç¯å€ã ïŒ äžèšåŒãã ãåŒäžãïŒïŒžåã³ïŒ²ã¯äžèšå®çŸ©ã«åããã ã§è¡šãããã26âããã²ã³åãã¿ãã³D3èªå°äœ
ãæå¹æåãšããè±è «çå€ã
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58153235A JPS6048963A (ja) | 1983-08-24 | 1983-08-24 | ïŒïŒâããã²ã³åãã¿ãã³ïœâïŒèªå°äœãã®è£œé æ³åã³ãããæå¹æåãšããè¬å€ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58153235A JPS6048963A (ja) | 1983-08-24 | 1983-08-24 | ïŒïŒâããã²ã³åãã¿ãã³ïœâïŒèªå°äœãã®è£œé æ³åã³ãããæå¹æåãšããè¬å€ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6048963A JPS6048963A (ja) | 1985-03-16 |
| JPS6357426B2 true JPS6357426B2 (ja) | 1988-11-11 |
Family
ID=15558002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58153235A Granted JPS6048963A (ja) | 1983-08-24 | 1983-08-24 | ïŒïŒâããã²ã³åãã¿ãã³ïœâïŒèªå°äœãã®è£œé æ³åã³ãããæå¹æåãšããè¬å€ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6048963A (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6421A (en) * | 1987-02-27 | 1989-01-05 | Teijin Ltd | Preventive for osteoporosis |
-
1983
- 1983-08-24 JP JP58153235A patent/JPS6048963A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6048963A (ja) | 1985-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3280975B2 (ja) | ïŒïŒâã¡ãã«â眮æãã¿ãã³ïœâèªå°äœ | |
| EP0184206B1 (en) | Vitamin d3 derivatives having a substituent at 2-position | |
| US4717721A (en) | Sidechain homo-vitamin D compounds with preferential anti-cancer activity | |
| US3901928A (en) | 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds | |
| US4670190A (en) | 1-α-hydroxy vitamin D compounds and process for preparing same | |
| EP0386793B1 (en) | Novel 1 alpha-hydroxyvitamin d2 epimer and derivatives | |
| GB2220660A (en) | 1 alpha hydroxy-vitamin-d compounds | |
| JPH0667899B2 (ja) | ïŒïŒâãã«âãã¿ãã³ïœååç© | |
| EP0296800B1 (en) | Vitamin d3 derivatives | |
| JPH0748343A (ja) | ãã¿ãã³ïœâïŒïŒâãã§ãã«ã¹ã«ãã³èªå°äœ | |
| US4857518A (en) | Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same | |
| JP2731839B2 (ja) | åæåããããã¿ãã³ïŒ€â²äžïŒâŒååç©ããã³å¯Ÿå¿ããïŒÎ±âããããã·ã«åèªå°äœ | |
| EP0562497A1 (en) | 1 alpha-hydroxy vitamins D7 and D4' processes for the preparation thereof and pharmaceutical compositions | |
| JPH10509715A (ja) | ïŒïŒïŒïŒïŒâãžãã«âãã¿ãã³ïœ ååç© | |
| JP2927368B2 (ja) | ïŒÎ±âããããã·âïŒïŒââãã¿ãã³ïŒ€â²äžïŒâŒ | |
| EP0055999B1 (en) | Vitamin d3 | |
| JPH02504149A (ja) | ïŒÎ±âããããã·ãã¿ãã³ïŒ€åæäœ | |
| JPH05222089A (ja) | ïŒÎ±ïŒïŒÎ²ïŒïŒïŒâããªããããã·âïŒïŒâãã¢ã³ã¬ã¹ã¿âïŒïŒïŒïŒâãžãšã³ååç© | |
| JPS62501505A (ja) | ãã¿ãã³ïœèªå°äœ | |
| JPS6357425B2 (ja) | ||
| JPS6357424B2 (ja) | ||
| NO972257L (no) | 18-nor-vitamin D-forbindelser | |
| JPH0635474B2 (ja) | ãã¿ãã³ïœé¢é£ååç© | |
| JPS6048963A (ja) | ïŒïŒâããã²ã³åãã¿ãã³ïœâïŒèªå°äœãã®è£œé æ³åã³ãããæå¹æåãšããè¬å€ | |
| JPH0625155A (ja) | ïŒïŒâã¡ãã«ãã¿ãã³ïœèªå°äœ |